<SEC-DOCUMENT>0001193125-22-289156.txt : 20221118
<SEC-HEADER>0001193125-22-289156.hdr.sgml : 20221118
<ACCEPTANCE-DATETIME>20221118172735
ACCESSION NUMBER:		0001193125-22-289156
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20221118
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20221118
DATE AS OF CHANGE:		20221118

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HONEYWELL INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000773840
		STANDARD INDUSTRIAL CLASSIFICATION:	AIRCRAFT ENGINES & ENGINE PARTS [3724]
		IRS NUMBER:				222640650
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08974
		FILM NUMBER:		221402937

	BUSINESS ADDRESS:	
		STREET 1:		855 S. MINT STREET
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28202
		BUSINESS PHONE:		704-627-6200

	MAIL ADDRESS:	
		STREET 1:		855 S. MINT STREET
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALLIEDSIGNAL INC
		DATE OF NAME CHANGE:	19940929
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>d393319d8ka.htm
<DESCRIPTION>8-K/A
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hon="http://honeywell.com/20221118" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K/A</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2022-11-18_to_2022-11-18">HONEYWELL INTERNATIONAL INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2022-11-18_to_2022-11-18">true</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2022-11-18_to_2022-11-18">0000773840</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="hon-20221118.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2022-11-18_to_2022-11-18"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000773840</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-18</xbrli:startDate> <xbrli:endDate>2022-11-18</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000773840</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-18</xbrli:startDate> <xbrli:endDate>2022-11-18</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes130Due2023Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000773840</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hon:EuroNotes130Due2023Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-18</xbrli:startDate> <xbrli:endDate>2022-11-18</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.000SeniorNotesDue2024Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000773840</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hon:M0.000SeniorNotesDue2024Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-18</xbrli:startDate> <xbrli:endDate>2022-11-18</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes225Due2028Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000773840</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hon:EuroNotes225Due2028Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-18</xbrli:startDate> <xbrli:endDate>2022-11-18</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.750SeniorNotesDue2032Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000773840</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hon:M0.750SeniorNotesDue2032Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2022-11-18</xbrli:startDate> <xbrli:endDate>2022-11-18</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">Form <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2022-11-18_to_2022-11-18">8-K/A</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Amendment No.&#160;1)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO SECTION 13 OR 15(D)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">OF THE SECURITIES EXCHANGE ACT OF 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">DATE OF REPORT - <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2022-11-18_to_2022-11-18" format="ixt:datemonthdayyearen">November&#160;18, 2022</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Date of earliest event reported)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">HONEYWELL INTERNATIONAL INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of Registrant as specified in its Charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2022-11-18_to_2022-11-18" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2022-11-18_to_2022-11-18">1-8974</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2022-11-18_to_2022-11-18">22-2640650</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr></table> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:50%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:48%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2022-11-18_to_2022-11-18">855 South Mint Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2022-11-18_to_2022-11-18">Charlotte</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2022-11-18_to_2022-11-18">NC</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2022-11-18_to_2022-11-18">28202</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2022-11-18_to_2022-11-18">(704)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2022-11-18_to_2022-11-18">627-6200</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2022-11-18_to_2022-11-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2022-11-18_to_2022-11-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2022-11-18_to_2022-11-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2022-11-18_to_2022-11-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, par value $1 per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">HON</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes130Due2023Member">1.300% Senior Notes due 2023</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes130Due2023Member">HON 23A</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes130Due2023Member" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.000SeniorNotesDue2024Member">0.000% Senior Notes due 2024</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.000SeniorNotesDue2024Member">HON 24A</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.000SeniorNotesDue2024Member" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes225Due2028Member">2.250% Senior Notes due 2028</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes225Due2028Member">HON 28A</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes225Due2028Member" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.750SeniorNotesDue2032Member">0.750% Senior Notes due 2032</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.750SeniorNotesDue2032Member">HON 32</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.750SeniorNotesDue2032Member" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging Growth Company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2022-11-18_to_2022-11-18" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Explanatory Note </p> <ix:nonNumeric name="dei:AmendmentDescription" contextRef="duration_2022-11-18_to_2022-11-18"><p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&#160;18, 2022, Honeywell International Inc. (&#8220;Honeywell&#8221;) filed a Current Report on Form <span style="white-space:nowrap">8-K</span> (the &#8220;Original Form <span style="white-space:nowrap">8-K&#8221;)</span> with the Securities and Exchange Commission disclosing, among other things, that Honeywell had entered into a definitive agreement (the &#8220;Buyout Agreement&#8221;) with the North American Refractories Asbestos Personal Injury Settlement Trust (the &#8220;Trust&#8221;), providing for the elimination of Honeywell&#8217;s funding obligations to the Trust.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the Original Form <span style="white-space:nowrap">8-K,</span> Honeywell stated that it intended to file a copy of the Buyout Agreement as an exhibit to an amendment to the Original Form <span style="white-space:nowrap">8-K.</span> Honeywell is now filing this Amendment No.&#160;1 to the Original Form <span style="white-space:nowrap">8-K</span> (&#8220;Amendment No.&#160;1&#8221;) solely to file the Buyout Agreement as an exhibit. This Amendment No.&#160;1 does not change any previously reported information or any disclosure contained in the Original Form <span style="white-space:nowrap">8-K.</span></p> </ix:nonNumeric> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left">ITEM&#160;9.01</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="text-decoration:underline">Financial Statements and Exhibits</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit&#160;#</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d393319dex101.htm">Buyout Agreement, dated November&#160;18, 2022, between Honeywell International Inc. and the North American Refractories Asbestos Personal Injury Settlement Trust. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">HONEYWELL INTERNATIONAL INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: November&#160;18, 2022</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Anne T. Madden</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Anne T. Madden</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Senior Vice President and General Counsel</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d393319dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.1 </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>BUYOUT AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Buyout Agreement (the &#147;<B>Agreement</B>&#148;) is made and entered into as of November&nbsp;18, 2022 (the &#147;<B>Agreement
Date</B>&#148;), by and among (i)&nbsp;Honeywell International Inc., a Delaware corporation (&#147;<B>Honeywell</B>&#148;), (ii) the North American Refractories Asbestos Personal Injury Settlement Trust, a Delaware trust (the &#147;<B>NARCO Asbestos
Trust</B>&#148;), and, following their execution of this Agreement, (iii)&nbsp;the NARCO Trust Advisory Committee<B> </B>(the &#147;<B>NARCO Asbestos TAC</B>&#148;), and (iv)&nbsp;Lawrence Fitzpatrick, in his capacity as the NARCO Asbestos Future
Claimants Representative<B> </B>(the &#147;<B>FCR</B>&#148;) (each upon execution of this Agreement, a &#147;<B>Party</B>&#148; and collectively, the &#147;<B>Parties</B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS,<B>
</B>North American Refractories Company (&#147;<B>NARCO</B>&#148;) and its affiliated debtors (collectively, the &#147;<B>Debtors</B>&#148;) reorganized under the provisions of Chapter 11 of the Bankruptcy Code in cases pending in the United States
Bankruptcy Court for the Western District of Pennsylvania (the &#147;<B>Bankruptcy Court</B>&#148;) known as In re North American Refractories Company, et al., Jointly Administered as Case <FONT STYLE="white-space:nowrap">No.&nbsp;02-20198</FONT>
(the &#147;<B>Chapter 11 Cases</B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, at the time of the entry of the order for relief in the Chapter 11 Cases, each of
NARCO and Honeywell had been named as defendants in personal injury and wrongful death actions seeking recovery for damages allegedly caused by the presence of, or exposure to, asbestos-containing NARCO Product Line products; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, by order entered on November&nbsp;13, 2007, the Plan (as defined below) filed by the Debtors, in coordination with Honeywell, the
Bankruptcy Court-appointed committee composed of the representatives of the NARCO Asbestos Claimants, and the FCR, was confirmed by the Bankruptcy Court; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Plan provided for the creation of the NARCO Asbestos Trust, which was organized pursuant to that certain Certificate of Trust
dated as of April&nbsp;30, 2013; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Plan, the NARCO Asbestos Trust was funded (i)&nbsp;by an initial cash
contribution by Honeywell and by the obligation of Honeywell to make future contractual payments (the &#147;<B>Honeywell Obligations</B>&#148;); and (ii)&nbsp;by the NARCO Asbestos Trust&#146;s equity interest in HarbisonWalker International
Holdings, Inc., a Delaware corporation formerly known as ANH Refractories Company (&#147;<B>HWI</B>&#148; and such equity interest held by the NARCO Asbestos Trust in HWI, together with any equity interests or securities received by the NARCO
Asbestos Trust in connection with an HWI Sale or an HWI Dividend (each as defined below), the &#147;<B>HWI Interest</B>&#148;), together with any dividends or other income that may be distributed to the NARCO Asbestos Trust by HWI in respect of the
HWI Interest; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, pursuant to the Plan, the NARCO Asbestos Trust uses the NARCO Asbestos Trust Assets (as defined in the Plan) and
income to pay all valid NARCO Asbestos Trust Claims pursuant to the North American Refractories Company Asbestos Personal Injury Settlement Trust Distribution Procedures (as amended from time to time, the &#147;<B>TDP</B>&#148;), and is administered
in accordance with the North American Refractories Company Asbestos Personal Injury Settlement Trust Agreement (as amended from time to time, the &#147;<B>Trust Agreement</B>&#148;); </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the NARCO Asbestos Trust and Honeywell are each parties to that certain Amended and
Restated Cooperation Agreement, dated as of December&nbsp;11, 2013 (the &#147;<B>Cooperation Agreement</B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties
have an ongoing dispute about the proper administration of the NARCO Asbestos Trust; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, simultaneously with the execution of this
Agreement, the Parties have executed and filed a joint conditional stipulation of dismissal of the adversary proceeding styled <I>Honeywell International Inc. v. N. Am. Refractories Co. Asbestos Personal Injury Settlement Trust</I>, Adv. No. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">21-02097-TPA</FONT></FONT> (Bankr. W.D. Pa.), and no other action, suit, proceeding, complaint, or claim by or before any Governmental Authority is currently pending by any Party hereto
against any other Party hereto; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Honeywell desires to pay to the NARCO Asbestos Trust, and the NARCO Asbestos Trust desires to
accept from Honeywell, a lump sum, <FONT STYLE="white-space:nowrap">one-time</FONT> payment in the amount of $1,325,000,000 (subject to adjustment in accordance with the terms of this Agreement), in exchange for, among other things, the release of
Honeywell from all further and future monetary and/or other obligations of any kind (except as, and solely to the extent, set forth in this Agreement) to the NARCO Asbestos Trust, including but not limited to the Honeywell Obligations (the
&#147;<B>Buyout</B>&#148;); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Honeywell&#146;s willingness to pay the Buyout Amount (as defined below) is expressly conditioned
upon agreement among the Parties that (a)&nbsp;any HWI Net Sale Proceeds (as defined below) actually received by the NARCO Asbestos Trust with respect to the sale or disposition of its HWI Interest will accrue to the benefit of Honeywell, either in
the form of (i)&nbsp;a reduction in the Buyout Amount (if such HWI Net Sale Proceeds are actually received prior to the Closing) or (ii)&nbsp;a payment by the NARCO Asbestos Trust to Honeywell (if such HWI Net Sale Proceeds are actually received
after the Closing), as applicable and (b)&nbsp;any HWI Dividends (as defined below) actually received by the NARCO Asbestos Trust after the Closing will accrue to the benefit of Honeywell, and the NARCO Asbestos Trust will pay to Honeywell any
applicable HWI Net Dividends actually received by the NARCO Asbestos Trust after the Closing, in each case, as set forth herein; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties understand and agree that the Buyout and Honeywell&#146;s obligation to pay the Buyout Amount will not become effective
unless and until approved in all respects by the Bankruptcy Court, and any and all appeals are exhausted and/or defeated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE,
in consideration of the foregoing and the mutual covenants and agreements herein contained, and intending to be legally bound hereby, the Parties agree as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Definitions. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The following terms have the meanings set forth below for purposes of this Agreement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Approval Motion</B>&#148; means a Motion for Entry of an Order (i)&nbsp;Approving the NARCO Asbestos Trust Buyout Agreement and
(ii)&nbsp;Declaring the Buyout Agreement is Consistent with the Plan and Does Not Affect the NARCO Channeling Injunction. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Base Buyout Amount</B>&#148; means $1,325,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means any day, other than a Saturday, Sunday, or day on which commercial banks are required or authorized to
be closed in New York, New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Buyout Amount</B>&#148; means the Base Buyout Amount, <U>less</U> the aggregate amount of any
HWI Net Sale Proceeds with respect to an HWI Sale that is consummated prior to the Closing and actually received by the NARCO Asbestos Trust in cash prior to the Closing (if any), <U>plus</U> the Unpaid Claims Amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Final Order</B>&#148; means, as applicable, an order or judgment of the Bankruptcy Court, or other court of competent jurisdiction
with respect to the relevant subject matter, that has not been reversed, stayed, modified, or amended, and as to which the time to appeal, seek certiorari, or move for a new trial, reargument, or rehearing has expired and as to which no appeal,
petition for certiorari, or other proceeding for a new trial, reargument, or rehearing has been timely taken; or as to which, any appeal that has been taken or any petition for certiorari that has been or may be filed has been withdrawn with
prejudice, resolved by the highest court to which the order or judgment could be appealed or from which certiorari could be sought, or the new trial, reargument, or rehearing has been denied, resulted in no stay pending appeal or modification of
such order, or has otherwise been dismissed with prejudice; <U>provided</U>,<I> </I>that the possibility that a motion under Rule 60 of the Federal Rules of Civil Procedure, or any analogous rule under the Bankruptcy Rules, may be filed with respect
to such order will not preclude such order from being a Final Order. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Governmental Authority</B>&#148; means any court,
governmental department, commission, council, board, agency, bureau, authority or regulatory body or other instrumentality of the United States of America, any foreign jurisdiction, or any state, provincial, county, municipality or local
governmental unit thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HWI Charter</B>&#148; means the Amended and Restated Certificate of Incorporation of HWI, as amended
by the Certificate of Amendment, effective on December&nbsp;31, 2015. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HWI Dividends</B>&#148; means any dividends or
distributions of any kind, whether or not in cash, actually received by the NARCO Asbestos Trust after the Closing with respect to, derived from, relating to or arising out of the HWI Interest (excluding HWI Sale Proceeds and any HWI Special
Dividend). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HWI Governance Documents</B>&#148; means the HWI Charter, the bylaws of HWI and the HWI Shareholders Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HWI Net Dividends</B>&#148; means HWI Dividends, <U>less</U> any accrued or incurred and payable HWI Transaction Fees with respect to
such HWI Dividends (to the extent not previously deducted from the calculation of HWI Net Dividends), <U>less</U> any NARCO HWI Taxes with respect to such dividend (to the extent not previously deducted from the calculation of HWI Net Dividends).
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HWI Net Sale Proceeds</B>&#148; means any HWI Sale Proceeds, <U>less</U> any accrued or incurred and payable HWI Transaction
Fees with respect to such proceeds (to the extent not previously deducted from the calculation of HWI Net Sale Proceeds), <U>less</U> any NARCO HWI Taxes incurred with respect to such proceeds (to the extent not previously deducted from the
calculation of HWI Net Sale Proceeds). For the avoidance of doubt, HWI Net Sale Proceeds shall only include amounts actually received by the NARCO Asbestos Trust and, subject to <U>Section</U><U></U><U>&nbsp;3(a)(vii)</U>, shall not include any
proceeds, payments or consideration paid to third parties by or on behalf of the NARCO Asbestos Trust in connection with such HWI Sale. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HWI Sale Proceeds</B>&#148; means any payments, proceeds or consideration
(including any HWI Special Dividend), whether or not in cash, actually received by the NARCO Asbestos Trust with respect to or arising out of an HWI Sale. For the avoidance of doubt, HWI Sale Proceeds shall not include (i)&nbsp;any HWI Dividends or
(ii)&nbsp;any portion of the payments, proceeds or consideration in such HWI Sale to be paid to the NARCO Asbestos Trust that is contingent upon future events (including, without limitation, amounts held in escrow and/or any earnout or deferred
consideration) unless and until such proceeds are actually received by the NARCO Asbestos Trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HWI Sale</B>&#148; means
(i)&nbsp;a merger, acquisition, business combination or sale, disposition, assignment, or other transfer of any or all of the equity of HWI or any legal entity in which the NARCO Asbestos Trust holds any equity interest or other security following
completion of any prior HWI Sale or (ii)&nbsp;a sale, disposition, assignment or other transfer of all or substantially all of the assets of HWI and its subsidiaries or any legal entity in which the NARCO Asbestos Trust holds any equity interest or
other security following completion of any prior HWI Sale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HWI</B><B></B><B>&nbsp;Shareholders Agreement</B>&#148; means the
Amended and Restated Shareholders Agreement of HWI, dated as of December&nbsp;11, 2013, by and among HWI, the APG Asbestos Trust (&#147;<B>APG Trust</B>&#148;) and the NARCO Asbestos Trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HWI Special Dividend</B>&#148; means, to the extent permitted in accordance with the definitive agreement with respect to an HWI
Sale, any special cash dividends or distributions (i)&nbsp;paid in connection with, and on or within five (5)&nbsp;Business Days prior to, the closing of an HWI Sale and (ii)&nbsp;actually received by the NARCO Asbestos Trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>HWI Transaction Fees</B>&#148; means any documented
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees, costs and expenses (including any documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> legal,
shareholder representative, accounting, tax or financial advisory fees, costs or expenses) accrued or incurred and payable by the NARCO Asbestos Trust in connection with (i)&nbsp;any HWI Sale or (ii)&nbsp;HWI Dividend, including, in each case,
(A)&nbsp;documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees, costs and expenses of enforcing any rights in connection therewith or procuring any contingent consideration or other recovery
related to (x)&nbsp;an HWI Sale or (y)&nbsp;an HWI Dividend and (B)&nbsp;any documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees, costs and expenses related to any <FONT
STYLE="white-space:nowrap">non-cash</FONT> portion of any HWI Sale Proceeds or HWI Dividend, including the administration, valuation, appraisal or sale thereof. For the avoidance of doubt, HWI Transaction Fees exclude (i)&nbsp;any such <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees, costs or expenses paid or payable by HWI and (ii)&nbsp;any amounts previously paid by Honeywell to the NARCO Asbestos Trust in accordance with
<U>Section</U><U></U><U>&nbsp;3(b)(iv)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Independent Accountant</B>&#148; means an independent accounting or financial
valuation firm of national reputation (excluding the primary outside auditor of Honeywell and the primary outside auditor of NARCO Asbestos Trust) that is mutually agreed between Honeywell and the NARCO Asbestos Trust within ten (10)&nbsp;Business
Days, <U>provided</U>, that such Independent Account shall be retained at Honeywell&#146;s sole expense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Law</B>&#148; means all applicable laws, statutes, rules, regulations, codes,
ordinances, permits, bylaws, variances, policies, judgments, injunctions, orders, guidelines, conditions and licenses of a Governmental Authority having jurisdiction over the assets or the properties of any Party and the operations thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>NARCO HWI Taxes</B>&#148; means the sum of (x)&nbsp;any federal or state income taxes accrued or incurred and payable by or on behalf
of the NARCO Asbestos Trust in connection with any HWI Sale Proceeds received by the NARCO Asbestos Trust with respect to, derived from, relating to or arising out of the HWI Interest, calculated as (a)&nbsp;the excess (if any) of such HWI Sale
Proceeds over the NARCO Asbestos Trust&#146;s tax basis in the HWI Interest, or portion thereof, treated as exchanged for such HWI Sale Proceeds, <I>multiplied</I> by (b)&nbsp;the net combined federal and state tax rate applicable to trusts for the
year of the receipt of the HWI Sale Proceeds and (y)&nbsp;any other Taxes (to the extent not included in clause (x), above) of or payable by the NARCO Asbestos Trust with respect to, derived from, relating to or arising from HWI Sale Proceeds or HWI
Dividends, including with respect to the receipt, ownership or transfer of any <FONT STYLE="white-space:nowrap">non-cash</FONT> portion of any HWI Sale Proceeds or HWI Dividends, in each case, prepared and calculated consistent with the NARCO
Asbestos Trust&#146;s historic practice, if applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT STYLE="white-space:nowrap">Non-Cash</FONT> Transfer Date</B>&#148;
means the date that is the earlier of (a)&nbsp;such date as Honeywell directs the NARCO Asbestos Trust in writing and (b)&nbsp;twelve (12) months after the date the NARCO Asbestos Trust receives the applicable
<FONT STYLE="white-space:nowrap">non-cash</FONT> portion of any HWI Sale Proceeds or HWI Dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><FONT
STYLE="white-space:nowrap">Non-Honeywell</FONT> Parties</B>&#148; means the Parties hereto other than Honeywell. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Person</B>&#148; means an individual, corporation, partnership, limited liability company, limited liability partnership, syndicate,
person, trust, association, organization or other legal entity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Review and Dispute Procedures</B>&#148; shall mean the
procedures set forth in <U>Section</U><U></U><U>&nbsp;3(a)(ii)</U> to <U>(v)</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax</B>&#148; means any taxes and similar
assessments imposed by any Governmental Authority, including income, capital gains, gross receipts, net proceeds, sales, use, transfer, ad valorem, franchise, profits, license, capital, withholding, payroll, employment, real property, personal
property (tangible and intangible), environmental, stamp, excise, leasing, duty, registration, alternative and value added taxes, and with respect to the NARCO Asbestos Trust, any interest or any penalties incurred and payable by the NARCO Asbestos
Trust which result from an HWI Sale (and which are not the result of any gross negligence, fraud or willful and intentional breach or misconduct of the NARCO Asbestos Trust to pay any such taxes when due as determined by a court of competent
jurisdiction by final nonappealable judgment). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Unpaid Claims Amount</B>&#148; means an amount equal to the greater of
(x)&nbsp;the sum of the value of any NARCO Asbestos Trust Claims liquidated and entered into the Annual Contribution Claims Fund Payment Queue and the <FONT STYLE="white-space:nowrap">Pre-Established</FONT> Claims Fund Payment Queue (as such terms
are defined in the Existing Agreements) since the end of the last calendar quarter preceding the Closing (and unfunded by Honeywell as of the Closing) minus any amounts received by the NARCO Asbestos Trust from any of its holdings (including the HWI
Interests) since the end of the last calendar quarter preceding the Closing and (y)&nbsp;zero. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Capitalized terms used and not otherwise defined in this Agreement have the meanings
given to them in the Third Amended Plan of Reorganization of North American Refractories Company, et al., dated December&nbsp;28, 2005 (the &#147;<B>Plan</B>&#148;) and/or in the TDP (as defined above). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>2. The Buyout Payment. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Upon the terms and subject to the conditions of this Agreement, at the Closing (as defined below), Honeywell shall pay to the NARCO
Asbestos Trust the Buyout Amount set forth in the Closing Statement (as defined below) in immediately available funds in U.S. dollars by wire transfer to a bank account designated in writing by the NARCO Asbestos Trust in the Closing Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>3. Treatment of HWI Interest </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>HWI Payments</U>. From and after the Closing, the NARCO Asbestos Trust shall retain ownership of the HWI Interest until such time as
the HWI Interest is disposed of as contemplated by and pursuant to the terms of this Agreement. Subject to the terms and conditions in this Agreement, the economic right of the NARCO Asbestos Trust in the HWI Interest shall inure to the benefit of
Honeywell, and any and all HWI Net Sale Proceeds and HWI Net Dividends shall be delivered to Honeywell, or held for the benefit of Honeywell, in accordance with this <U>Section</U><U></U><U>&nbsp;3(a)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) From and after the Closing, within twenty (20)&nbsp;Business Days after receipt of any HWI Sale Proceeds or HWI Dividend,
the NARCO Asbestos Trust shall: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) pay to Honeywell the cash portion of such HWI Net Sale Proceeds or HWI Net Dividends
as set forth in the Estimated Post-Closing Statement delivered in accordance with <U>Section</U><U></U><U>&nbsp;3(a)(i)(2)</U> in immediately available funds in U.S. dollars by wire transfer to a bank account designated in writing by Honeywell;
<U>provided,</U> that Honeywell delivers to the NARCO Asbestos Trust bank account details at least two (2)&nbsp;Business Days prior to such payment date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) deliver to Honeywell a statement setting forth the amount of any HWI Sale Proceeds or HWI Dividends and the estimated HWI
Net Sale Proceeds or HWI Net Dividends to be delivered to Honeywell with respect to such HWI Sale Proceeds or HWI Dividends (as applicable) pursuant to <U>Section</U><U></U><U>&nbsp;3(a)(i)(1)</U>, with reasonable supporting detail (including copies
of invoices as well as the assumptions underlying the calculation of NARCO HWI Taxes) showing the calculation of such estimated HWI Net Sale Proceeds or HWI Net Dividends (each, an &#147;<B>Estimated </B><B>Post-Closing Statement</B>&#148;),
<U>provided</U>, that Honeywell shall be permitted to dispute the determination of the amount of the estimated HWI Net Sale Proceeds, HWI Net Dividends, HWI Transaction Fees and NARCO HWI Taxes set forth in each Estimated Post-Closing Statement, in
accordance with this <U>Section</U><U></U><U>&nbsp;3(a)</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Honeywell shall have twenty (20)&nbsp;Business Days from
the date of delivery of the Estimated Post-Closing Statement by the NARCO Asbestos Trust (the &#147;<B>Review Period</B>&#148;) to review such Estimated Post-Closing Statement. If Honeywell agrees with such Estimated Post-Closing Statement, or does
not give written notice to the NARCO Asbestos Trust of any disagreement within the Review Period, then upon the earlier of Honeywell&#146;s written notice to the NARCO Asbestos Trust advising that such statement is acceptable or the expiration of
the Review Period if Honeywell has not delivered a notice of dispute prior to such expiration, such Estimated Post-Closing Statement shall be considered final and binding on the NARCO Asbestos Trust and Honeywell. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) If Honeywell does not agree with any portion of the Estimated
Post-Closing Statement, then, on or before the expiration of the Review Period, Honeywell shall give written notice thereof to the NARCO Asbestos Trust and list the items and reasons for disagreement (the &#147;<B>Dispute Notice</B>&#148;). The
NARCO Asbestos Trust and Honeywell shall work in good faith to resolve the items listed in the Dispute Notice. If, within thirty (30)&nbsp;days after the delivery of the Dispute Notice to the NARCO Asbestos Trust (the &#147;<B>Resolution
Period</B>&#148;), the NARCO Asbestos Trust and Honeywell are unable to resolve any differences arising as a result of the Dispute Notice, NARCO Asbestos Trust and Honeywell shall each submit, within ten (10)&nbsp;days following the expiration of
the Resolution Period, a statement of such remaining disagreements and such party&#146;s proposed resolution thereof in the Dispute Notice to an Independent Accountant for a binding and <FONT STYLE="white-space:nowrap">non-appealable</FONT>
determination, which the NARCO Asbestos Trust and Honeywell shall request be rendered within thirty (30)&nbsp;days after such submission. The costs and expenses of the Independent Accountant shall be borne by Honeywell. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) The Independent Accountant shall be instructed to use reasonable best efforts to perform its services and reach a final
determination with respect to the matters submitted to it for resolution within thirty (30)&nbsp;days of its engagement, <U>provided</U>, that in resolving any disputed item, the Independent Accountant, acting as an expert and not as an arbitrator
or independent reviewer, shall be bound by the terms, conditions, procedures and provisions of this <U>Section</U><U></U><U>&nbsp;3(a)</U> and any other relevant provisions of this Agreement, and the Independent Accountant&#146;s final determination
with respect to any disputed item shall not be less than the lowest amount or greater than the highest amount proposed by the NARCO Asbestos Trust and Honeywell in their respective submitted proposed resolutions for such disputed item. The Parties
shall request that the Independent Accountant&#146;s decision be in writing, set forth the calculations made in reaching its decision and describe the manner in which such calculations were made. The Parties acknowledge and agree that the decision
by the Independent Accountant shall be <FONT STYLE="white-space:nowrap">non-appealable</FONT> and binding on the Parties. Each of the NARCO Asbestos Trust and Honeywell agrees that they will, and agree to direct their respective representatives to,
cooperate and assist in the determination with respect to the matters submitted to the Independent Accountant for resolution and in the conduct of the review by the other party and its representatives or, if applicable, the Independent Accountant of
any proposed calculations of the HWI Net Sale Proceeds or HWI Net Dividends or the components thereof, including by making available, to the extent reasonably necessary, relevant books, records, accountant or tax advisor work papers (but subject to
execution by Honeywell of customary <FONT STYLE="white-space:nowrap">non-reliance</FONT> agreements) and advisors; <U>provided</U>, that nothing herein shall require either Party to make available any books, records or work papers prepared by the
NARCO Asbestos Trust&#146;s attorneys or that would otherwise reasonably be expected to result in the waiver of any applicable attorney-client or attorney work product privilege. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) Within five (5)&nbsp;Business Days after the applicable cash portion of
the HWI Net Sale Proceeds or HWI Net Dividends is determined pursuant to this <U>Section</U><U></U><U>&nbsp;3(a)</U>: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)
if the cash portion of the HWI Net Sale Proceeds or HWI Net Dividends as determined pursuant to this <U>Section</U><U></U><U>&nbsp;3(a)</U> is greater than the cash portion of the estimated HWI Net Sale Proceeds or estimated HWI Net Dividends set
forth in the applicable Estimated Post-Closing Statement, then the NARCO Asbestos Trust shall pay to Honeywell a cash amount equal to such excess in immediately available funds in U.S. dollars by wire transfer to a bank account designated in writing
by Honeywell; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if the cash portion of the HWI Net Sale Proceeds or HWI Net Dividends as determined pursuant to this
<U>Section</U><U></U><U>&nbsp;3(a)</U> is less than the cash portion of the estimated HWI Net Sale Proceeds or estimated HWI Net Dividends set forth in the applicable Estimated Post-Closing Statement, then Honeywell shall pay to the NARCO Asbestos
Trust a cash amount equal to such deficit in immediately available funds in U.S. dollars by wire transfer to a bank account designated in writing by the NARCO Asbestos Trust. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) From and after the Agreement Date until the applicable <FONT STYLE="white-space:nowrap">Non-Cash</FONT> Transfer Date, the
NARCO Asbestos Trust shall hold the <FONT STYLE="white-space:nowrap">non-cash</FONT> portion of any HWI Net Sale Proceeds or HWI Net Dividends (if any) for the benefit of Honeywell. No later than twenty (20)&nbsp;Business Days prior to the
applicable <FONT STYLE="white-space:nowrap">Non-Cash</FONT> Transfer Date, Honeywell shall deliver a written notice to the NARCO Asbestos Trust setting forth applicable delivery instructions with respect to such
<FONT STYLE="white-space:nowrap">non-cash</FONT> portion of any HWI Net Sale Proceeds or HWI Net Dividends (a &#147;<B><FONT STYLE="white-space:nowrap">Non-Cash</FONT> Notice</B>&#148;). On the applicable
<FONT STYLE="white-space:nowrap">Non-Cash</FONT> Transfer Date, the NARCO Asbestos Trust shall: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) transfer such <FONT
STYLE="white-space:nowrap">non-cash</FONT> HWI Net Sale Proceeds or HWI Net Dividends to Honeywell in accordance with the <FONT STYLE="white-space:nowrap">Non-Cash</FONT> Notice. If requested in writing by Honeywell in a <FONT
STYLE="white-space:nowrap">Non-Cash</FONT> Notice, the NARCO Asbestos Trust shall effect a disposition of such <FONT STYLE="white-space:nowrap">non-cash</FONT> portion of any HWI Net Sale Proceeds or HWI Net Dividends in accordance with
<U>Section</U><U></U><U>&nbsp;3(a)(vi)</U> and <U>Section</U><U></U><U>&nbsp;3(b)</U>. Honeywell shall pay any HWI Transaction Fees or NARCO HWI Taxes in cash with respect to the <FONT STYLE="white-space:nowrap">non-cash</FONT> portion of any HWI
Sale Proceeds and HWI Dividends (to the extent not previously paid or deducted from the calculation of HWI Net Sale Proceeds or HWI Net Dividends) (the &#147;<B>Incremental HWI Transaction Fees and Taxes</B>&#148;) at the time such Incremental HWI
Transaction Fees and Taxes become due and payable by the NARCO Asbestos Trust (plus an amount of additional consideration necessary to compensate the NARCO Asbestos Trust for any additional Taxes owed as a result of such payment unless Treasury
Regulation <FONT STYLE="white-space:nowrap">1.468B-2(b)(1)</FONT> excludes such payments from gross income), <U>provided</U>, that, in the event the NARCO Asbestos Trust receives publicly traded securities in a legal entity as part of the
consideration in an HWI Sale, Honeywell may, in its sole discretion and at its sole cost and expense, direct the NARCO Asbestos Trust to sell the portion of such securities that are necessary for the NARCO Asbestos Trust to pay any such Incremental
HWI Transaction Fees and Taxes, in lieu of Honeywell making such payments directly (which amount to be sold shall be sufficient to pay any Incremental HWI Transaction Fees and Taxes payable in connection with such sale or shall be otherwise paid by
Honeywell to the NARCO Asbestos Trust directly). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) deliver to Honeywell a statement setting forth the estimated amount of
any Incremental HWI Transaction Fees and Taxes, with reasonable supporting detail (including copies of invoices as well as the assumptions underlying the calculation of NARCO HWI Taxes) showing the calculation of such estimated Incremental HWI
Transaction Fees and Taxes (each, an &#147;<B>Estimated Incremental Fees and Taxes Statement</B>&#148;), <U>provided</U>, that Honeywell shall be permitted to dispute the determination of the amount of the estimated
<FONT STYLE="white-space:nowrap">non-cash</FONT> HWI Net Sale Proceeds or HWI Net Dividends and estimated HWI Transaction Fees and NARCO HWI Taxes set forth in each Estimated Incremental Fees and Taxes Statement, in accordance with the Review and
Dispute Procedures. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Review and Dispute Procedures set forth in <U>Sections 3(a)(ii)</U> to <U>(v)</U>&nbsp;above with respect the
Estimated Post-Closing Statement shall also apply to the Estimated Incremental Fees and Taxes Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) The NARCO
Asbestos Trust shall not direct or otherwise cause any portion of any HWI Sale Proceeds or HWI Dividends to be paid or delivered to any third parties (other than any payments made in respect of HWI Transaction Fees and NARCO HWI Taxes or made
pursuant to the terms of any definitive transaction agreement providing for an HWI Sale). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii) Notwithstanding, anything
to the contrary contained in this Agreement, in the event any NARCO HWI Taxes are determined by the Internal Revenue Service or other Governmental Authority by a final nonappealable judgment or determination to be greater than the NARCO HWI Taxes
determined pursuant to this <U>Section</U><U></U><U>&nbsp;3(a)</U>, <U>Section</U><U></U><U>&nbsp;5(a)</U> or the Review and Dispute Procedures (such excess amount, the &#147;<B>Excess Taxes</B>&#148;), as promptly as practicable (but no later than
ten (10)&nbsp;Business Days after such final determination), Honeywell shall pay to the NARCO Asbestos Trust an amount equal to the sum of (i)&nbsp;the Excess Taxes and (ii)&nbsp;any HWI Transaction Fees incurred and paid or payable in connection
with the determination of such Excess Taxes, except to the extent any of the foregoing is determined by a court of competent jurisdiction by final nonappealable order to have resulted from the gross negligence, fraud or willful and intentional
misconduct by the NARCO Asbestos Trust. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix) Notwithstanding, anything to the contrary contained in this Agreement, in the
event any NARCO HWI Taxes are determined by the Internal Revenue Service or other Governmental Authority by a final nonappealable judgment or determination to be less than the NARCO HWI Taxes determined pursuant to this
<U>Section</U><U></U><U>&nbsp;3(a)</U>, <U>Section</U><U></U><U>&nbsp;5(a)</U> or the Review and Dispute Procedures (such amount, the &#147;<B>Residual Taxes</B>&#148;), as promptly as practicable (but no later than ten (10)&nbsp;Business Days after
such final determination), the NARCO Asbestos Trust shall pay to Honeywell an amount equal to the Residual Taxes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>HWI Governance Documents and HWI Sale</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) From and after the Agreement Date, the NARCO Asbestos Trust shall promptly and without undue delay enforce all of its
rights under the HWI Governance Documents as directed in writing by Honeywell and at Honeywell&#146;s sole cost and expense, subject to the terms of the HWI Governance Documents and any applicable fiduciary duties of the NARCO Asbestos Trust. From
and after the Agreement Date until the date on which the NARCO Asbestos Trust ceases to hold any HWI Interests, the NARCO Asbestos Trust shall not (A)&nbsp;terminate, amend or modify, reduce, or waive any of its or Honeywell&#146;s rights under, the
HWI Governance Documents (including Article IX of the HWI Charter), or take any other action to eliminate or diminish the rights of Honeywell or the NARCO Asbestos Trust thereunder or (B)&nbsp;sell, transfer, dispose of or encumber any portion of
its HWI Interest, in each case, without the prior written consent of Honeywell (such consent not to be unreasonably withheld, conditioned or delayed). If, subject to the HWI Governance Documents and any applicable duties of the NARCO Asbestos Trust,
the NARCO Asbestos Trust initiates a claim or legal action to enforce its rights under the HWI Governance Documents against a third-party (other than Honeywell), at Honeywell&#146;s written request, the NARCO Asbestos Trust shall permit Honeywell to
control the prosecution of such claim or action at Honeywell&#146;s sole cost and expense; provided, that Honeywell shall not, and the NARCO Asbestos Trust shall not be obligated to, settle any such claim or action which settlement
(x)&nbsp;obligates NARCO Asbestos Trust or Trustees to perform obligations (including to refrain from taking any actions) or imposes equitable remedies, (y)&nbsp;obligates NARCO Asbestos Trust or Trustees to admit wrongdoing or liability, or
(z)&nbsp;does not cause the NARCO Asbestos Trust and Trustees to be fully and unconditionally released from all liability with respect to such claim; <U>provided</U>, further that Honeywell shall allow the NARCO Asbestos Trust an opportunity to
participate in the prosecution of such claim or action with NARCO Asbestos Trust&#146;s own counsel and at its own expense. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) The Parties acknowledge that the expected monetization of the HWI Interest on the terms and conditions set forth herein
are material terms to this Agreement and are a material part of the consideration for the promises and undertakings contemplated herein, including the payment of the Buyout Amount. From and after the Closing until the NARCO Asbestos Trust no longer
holds any HWI Interest, Honeywell may deliver written notice to HWI and the NARCO Asbestos Trust that Honeywell desires to cause either (x)&nbsp;an HWI Sale and/or (y)&nbsp;a sale of a material portion of the assets of HWI and its subsidiaries (any
transaction described in clause (x)&nbsp;or (y), an &#147;<B>HWI Transaction</B>&#148;) and such written notice shall set forth the proposed material terms and conditions of such HWI Transaction (such written notice, the &#147;<B>Sale
Notice</B>&#148;). Upon receipt of a Sale Notice, subject to the terms of the HWI Governance Documents and any applicable fiduciary duties of the NARCO Asbestos Trust, the NARCO Asbestos Trust shall, at Honeywell&#146;s sole cost and expense,
cooperate with Honeywell and HWI to facilitate, as promptly as practicable, such HWI Transaction in accordance with the Sale Notice and shall not take any action that would reasonably be expected to prevent, materially delay, impair or impede an HWI
Transaction, unless such action is consented to in writing by Honeywell. Without limiting the foregoing or anything else contained herein, subject to the terms of the HWI Governance Documents and any applicable fiduciary duties of the NARCO Asbestos
Trust, upon the written direction of Honeywell and at Honeywell&#146;s sole cost and expense, the NARCO Asbestos Trust shall, as promptly as practicable, (A)&nbsp;exercise the rights held by the Supermajority (as defined in the HWI Shareholders
Agreement) set forth in Section&nbsp;6 of the HWI Shareholders Agreement; (B)&nbsp;if such HWI Transaction requires shareholder approval, with respect to the HWI Interest, vote such equity (in person, by proxy or by
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
action by written consent, as applicable) in favor of such transaction and vote in opposition to any and all other proposals that could reasonably be expected to delay or impair the ability of
HWI to consummate such transaction; (C)&nbsp;not deposit any HWI Interest owned by the NARCO Asbestos Trust in a voting trust or subject any such HWI Interest to any arrangement or agreement with respect to the voting of such equity;
(D)&nbsp;refrain from asserting any claim or commencing any suit (x)&nbsp;challenging such HWI Transaction, or (y)&nbsp;alleging a breach of any fiduciary duty of the board of directors of HWI (the &#147;<B>HWI</B> <B>Board</B>&#148;) or any
affiliate or associate thereof (including, without limitation, aiding and abetting breach of fiduciary duty) in connection with the evaluation, negotiation, or approval of, or entry into, such HWI Transaction; (E)&nbsp;execute and deliver all
related documentation and taking such other action in support of the HWI Transaction as shall reasonably be requested in writing by Honeywell, including, without limitation, executing and delivering instruments of conveyance and transfer, and any
purchase agreement, merger agreement, any associated indemnity agreement or escrow agreement, any associated voting, support, or joinder agreement, consent, waiver, governmental filing, share certificates duly endorsed for transfer (free and clear
of any liens, claims and encumbrances, other than those arising under applicable securities laws, this Agreement or the HWI Governance Documents), and any similar or related documents; (F)&nbsp;exercise its rights and defenses and complying with its
obligations with respect to the HWI Transaction as a &#147;seller&#148;; and (G)&nbsp;delegate its authority to Honeywell to act as its agent with respect to matters customarily delegated to a &#147;seller&#146;s representative&#148; pursuant to an
HWI Transaction (for the avoidance of doubt, the NARCO Asbestos Trust does not control any other stockholder of HWI). The NARCO Asbestos Trust shall consult with Honeywell before taking any actions with respect to its equity stake in HWI. The NARCO
Asbestos Trust may not enter into a definitive agreement with respect to, consent to, approve or consummate an HWI Transaction without the prior written consent of Honeywell. In connection with any HWI Transaction, the NARCO Asbestos Trust shall
cooperate to provide that Honeywell, to the maximum extent permitted under the HWI Governing Documents, has the opportunity to participate in all material discussions with advisors and counterparties related thereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) Notwithstanding anything to the contrary contained herein, the NARCO Asbestos Trust shall not be obligated or required:
(1)&nbsp;to make any representations or warranties with respect to such HWI Transaction other than customary representations and warranties as to (x)&nbsp;its ownership of its HWI Interests, organization, authority, power and qualification, and
brokers (collectively, the &#147;<B>Fundamental Representations</B>&#148;) and (y)&nbsp;no litigation, compliance with laws, absence of governmental orders, consents of governmental authorities and third parties, breach or violation of
organizational documents, and authority and right to enter into and consummate (and no conflicts regarding) the HWI Transaction, in each case, solely with respect to the NARCO Asbestos Trust; (2)&nbsp;to be subject to any release (in a capacity
other than as an equityholder of HWI), <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> or <FONT STYLE="white-space:nowrap">non-hire</FONT> or similar covenants with respect to the
sale; (3)&nbsp;to agree to any indemnification obligations unless (A)&nbsp;the sole and exclusive recovery therefor is to an escrow or holdback established under the terms of the definitive agreement with respect to such HWI Transaction (and such
escrowed or holdback funds are excluded from HWI Sale Proceeds until released from such escrow or holdback to, and actually received by, the NARCO Asbestos Trust), (B) Honeywell agrees to backstop such NARCO Asbestos Trust&#146;s indemnification
obligations concurrently with the execution </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
by the NARCO Asbestos Trust of the definitive agreement with respect to such HWI Transaction or (C)&nbsp;the indemnification obligations relate to breaches of Fundamental Representations of the
NARCO Asbestos Trust; (4)&nbsp;to be responsible or have any liability for breaches of representations or covenants in connection with, arising out of or related to any such HWI Transaction by any other shareholder or HWI (other than such liability
that is limited to indemnification obligations solely to the extent permitted under the foregoing clause (3)(A) or (3)(B)); and/or (5)&nbsp;with respect to an HWI Transaction in which HWI is a constituent to a merger and/or is party to the
definitive agreement for such HWI Transaction, to enter into any definitive agreement or HWI Transaction unless such agreement and HWI Transaction has been approved and recommended by the HWI Board. In the event HWI and/or Honeywell engage a
financial advisor in connection with an HWI Transaction and the Trustees are not permitted to rely on any advice or opinion of such financial advisor, then the Trustees shall only be permitted to retain Kroll, LLC or another financial advisor
mutually acceptable to the NARCO Asbestos Trust and Honeywell, at Honeywell&#146;s sole cost and expense. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) Honeywell
shall, at the NARCO Asbestos Trust&#146;s request, promptly reimburse the NARCO Asbestos Trust for documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by the NARCO Asbestos Trust
in connection with an HWI Transaction regardless of whether such HWI Transaction is consummated. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) From and after the
closing of any HWI Transaction in which the NARCO Asbestos Trust receives as consideration any equity interest or other security in any legal entity, any references in the foregoing <U>Section</U><U></U><U>&nbsp;3(b)</U> to (1)&nbsp;HWI or the HWI
Board shall be deemed to refer to such legal entity or the governing body of such legal entity, as applicable and (2)&nbsp;the HWI Charter, bylaws of HWI or HWI Shareholders Agreement, or any HWI Governance Document shall be deemed to refer to the
applicable charter, bylaws or other governing documents of such legal entity, including any shareholders agreement or similar document; <U>provided</U>, that the rights and obligations of the NARCO Asbestos Trust under such applicable charter,
bylaws or other governing documents shall be materially consistent with, and no more onerous in the aggregate than, this Agreement and the HWI Governance Documents in place as of the Agreement Date. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Governance Matters</U><I>.</I> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) From and after the Closing, in the event the NARCO Asbestos Trust is entitled to nominate a director to the HWI Board, the
trustees of the NARCO Asbestos Trust (&#147;<B>Trustees</B>&#148;) agree to select the NARCO Asbestos Trust&#146;s nominee from a panel provided by Honeywell and will consult with Honeywell on the selection of such successor director. Honeywell will
provide the Trustees with biographical information reasonably requested by the Trustees regarding the persons included in the panel provided by Honeywell or any person that Honeywell proposes for the NARCO Asbestos Trust to nominate as a successor
director. Upon the written request of Honeywell, the Trustees shall, and shall cause the NARCO Asbestos Trust to, take all actions necessary to promptly remove any or all directors appointed by the NARCO Asbestos Trust designated in such request
from the HWI Board and nominate one or more successors in accordance with the foregoing procedures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) From and after the Closing, whenever the consent, approval, waiver or
vote of (A)&nbsp;the Trustees and/or the NARCO Asbestos Trust is requested by HWI or proposed by the Trustees and/or the NARCO Asbestos Trust or (B)&nbsp;the Trustees and/or the NARCO Asbestos Trust, on the one hand, and Honeywell, on the other
hand, are requested by HWI pursuant to the HWI Charter, the HWI Shareholders Agreement or applicable Law, the procedures set forth below shall apply to the Trustees, the NARCO Asbestos Trust and Honeywell, as applicable: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) The NARCO Asbestos Trust shall, and shall cause the Trustees to, promptly provide Honeywell with: (i)&nbsp;written notice
stating that either or both the Trustees&#146; and the NARCO Asbestos Trust&#146;s consent, approval, waiver or vote is being sought by HWI or proposed by the Trustees and/or the NARCO Asbestos Trust and (ii)&nbsp;copies of all written documentation
and other materials provided by or on behalf of HWI, the Trustees and/or the NARCO Asbestos Trust in connection with such request or proposal for consent, approval, waiver or vote. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) The Trustees and representatives of Honeywell shall promptly enter into good faith discussions regarding the Trustees&#146;
and/or the NARCO Asbestos Trust&#146;s and, if applicable, Honeywell&#146;s response or proposal for consent, approval, waiver or vote and seek to reach agreement among the parties hereto on such response or proposal. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) If, after following the procedures specified in this <U>Section</U><U></U><U>&nbsp;3(c)(ii)</U>, the Trustees and/or the
NARCO Asbestos Trust and Honeywell are unable to reach agreement on such response or proposal, the Trustees, the NARCO Asbestos Trust and Honeywell agree to resolve the dispute pursuant to Section&nbsp;8.14 of the Trust Agreement as such agreement
is in effect as of the Agreement Date as if such provisions were set forth herein, <I>mutatis mutandis</I>, before providing HWI such response or proposal. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) From and after the Closing, the Trustees shall, and shall cause the NARCO Asbestos Trust to, comply with the consent and
other rights of Honeywell identified in Article IX of the HWI Charter as if those rights were set forth herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) From
and after the closing of any HWI Sale in which the NARCO Asbestos Trust receives as consideration any equity interest or other security in any legal entity, any references in the foregoing <U>Section</U><U></U><U>&nbsp;3(c)</U> to (1)&nbsp;HWI or
the HWI Board shall be deemed to refer to such legal entity or the governing body of such legal entity, as applicable and (2)&nbsp;the HWI Charter, bylaws of HWI or HWI Shareholders Agreement, or any HWI Governance Document shall be deemed to refer
to the applicable charter, bylaws or other governing documents of such legal entity, including any shareholders agreement or similar document; <U>provided</U>, that the rights and obligations of the NARCO Asbestos Trust under such applicable
charter, bylaws or other governing documents shall be materially consistent with, and no more onerous in the aggregate than, this Agreement and the HWI Governance Documents in place as of the Agreement Date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Indemnity</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) From and after the Agreement Date, Honeywell shall indemnify and defend the Trustees and the NARCO Asbestos Trust against
any and all liabilities, documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses, claims, damages or losses incurred by the Trustees and/or the NARCO Asbestos Trust (1)&nbsp;in their
performance of the terms of <U>Section</U><U></U><U>&nbsp;3(b)</U> (including, for the avoidance of doubt, in connection with actions contemplated in clause (D)&nbsp;of <U>Section</U><U></U><U>&nbsp;3(b)(ii))</U>,
<U>Section</U><U></U><U>&nbsp;3(c)</U> and <U>Section</U><U></U><U>&nbsp;9(c)</U> of this Agreement (including any act or omission to act) and (2)&nbsp;arising out of, related to or in connection with an HWI Transaction, including the evaluation,
negotiation or approval of, or entry into such HWI Transaction, in each case of clause (1)&nbsp;and (2), except to the extent any of the foregoing is determined by a court of competent jurisdiction by final nonappealable judgement to have resulted
from the gross negligence, fraud, or willful and intentional misconduct or breach by the NARCO Asbestos Trust or the Trustees. For the avoidance of doubt, disputes with respect to actions requested by Honeywell to be taken under this Agreement,
including <U>Section</U><U></U><U>&nbsp;3(b)</U>, <U>Section</U><U></U><U>&nbsp;3(c)</U> or <U>Section</U><U></U><U>&nbsp;9(c),</U> do not constitute a breach by the Trustees for purposes of this <U>Section</U><U></U><U>&nbsp;3(d)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) The NARCO Asbestos Trust shall notify Honeywell in writing (a &#147;<B>Claims Notice</B>&#148;) of any pending or
threatened claim or demand that the NARCO Asbestos Trust has determined, has given, or would reasonably be expected to give rise to, a right of indemnification under this Agreement (including any pending or threatened claim or demand asserted by a
third party against the NARCO Asbestos Trust, such claim being a &#147;<B>Third Party Claim</B>&#148;), describing in reasonable detail the facts and circumstances giving rise to such claim or demand (to the extent then known) and thereafter shall
keep Honeywell reasonably informed (on a prompt basis) with respect thereto. Such Claims Notice shall be delivered to Honeywell as promptly as practicable after the NARCO Asbestos Trust acquires actual knowledge of such claim or demand;
<U>provided</U>, that the failure to provide such Claims Notice shall not release Honeywell from any of its obligations under this <U>Section</U><U></U><U>&nbsp;3(d)</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) With respect to any Third Party Claim, Honeywell may, by notice to the NARCO Asbestos Trust delivered within twenty
(20)&nbsp;Business Days of the receipt by Honeywell of a Claims Notice with respect to such Third Party Claim, assume the defense and control of (including, subject to this Section&nbsp;3(d)(iii), control of the negotiation and settlement of) such
Third-Party Claim, with its own counsel and at its own expense, and the NARCO Asbestos Trust shall cooperate with Honeywell in connection therewith; <U>provided</U>, that Honeywell shall allow the NARCO Asbestos Trust an opportunity to participate
in the defense of such Third Party Claim with its own counsel and at its own expense; <U>provided</U>, <U>however</U>, that Honeywell shall not be entitled to assume or continue control of such defense if (1)&nbsp;such Third Party Claim seeks
injunctive, equitable or other <FONT STYLE="white-space:nowrap">non-monetary</FONT> relief (other than a Third Party Claim that seeks injunctive, equitable or other <FONT STYLE="white-space:nowrap">non-monetary</FONT> relief solely to prevent the
consummation of an HWI Sale), (2) such Third-Party Claim involves criminal or quasi-criminal allegations, or (3)&nbsp;NARCO Asbestos Trust has been advised by counsel that an actual conflict of interest between Honeywell and the NARCO Asbestos Trust
or Trustees exists. To the extent Honeywell elects not to defend such Third Party Claim, or is not entitled to defend such Third Party Claim pursuant to this <U>Section</U><U></U><U>&nbsp;3(d)(iii)</U>, and the NARCO Asbestos Trust defends against
or otherwise deals therewith, the NARCO Asbestos Trust may retain counsel at the sole expense of Honeywell. The Party controlling the defense of a Third Party Claim shall keep the other Party reasonably advised of the status of such action, suit or
proceeding and the defense thereof. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
NARCO Asbestos Trust shall not pay or settle any such Third Party Claim without the prior written consent of Honeywell (such consent not to be unreasonably withheld, conditioned or delayed), and
the NARCO Asbestos Trust shall, at the written request of Honeywell, pay or settle any such Third Party Claim if (A)&nbsp;the sole relief provided is monetary damages and Honeywell pays all amounts arising out of such settlement that are due at the
effectiveness of such settlement, (B)&nbsp;there is no finding or admission adverse to the NARCO Asbestos Trust or the Trustees, and (C)&nbsp;the NARCO Asbestos Trust and Trustees are granted an unconditional release from all liability with respect
to such Third Party Claim. For the avoidance of doubt, Honeywell shall not, and the NARCO Asbestos Trust shall not be obligated to, settle any Third Party Claim which settlement (x)&nbsp;obligates NARCO Asbestos Trust or Trustees to perform
obligations (including to refrain from taking any actions) or imposes equitable remedies, (y)&nbsp;obligates NARCO Asbestos Trust or Trustees to admit wrongdoing or liability, or (z)&nbsp;does not cause the NARCO Asbestos Trust and Trustees to be
fully and unconditionally released from all liability with respect to such claim. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) The NARCO Asbestos Trust shall
(A)&nbsp;cooperate with Honeywell in the defense or prosecution of any Third-Party Claim in respect of which indemnity may be sought hereunder, (B)&nbsp;furnish to Honeywell such records, information, access to relevant personnel and testimony;
<U>provided</U>, that nothing herein shall require the NARCO Asbestos Trust to make available any records or information that could jeopardize or result in the waiver of any applicable attorney-client or attorney work product privilege and
(C)&nbsp;attend such conferences, discovery proceedings, hearings, trials and appeals, as may be reasonably requested by Honeywell in connection therewith, in each case of clauses (A), (B), and (C), at the sole cost and expense of Honeywell. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Amended and Existing Agreements. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Upon the terms and subject to the conditions of this Agreement, each of the Parties hereto have delivered fully executed signature pages
and agree that the following agreements shall be amended, restated and replaced effective as of the Closing: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the
Second Amended TDP (the &#147;<B>Existing TDP</B>&#148;) shall be amended, restated, and replaced by the &#147;Third Amended and Restated TDP&#148; attached hereto as <B><U>Exhibit A</U></B> (the &#147;<B>Amended NARCO Asbestos TDP</B>&#148;). A
redline showing the changes the Parties made to the Existing TDP pursuant to this Agreement is attached hereto as <B><U>Exhibit AA</U></B>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the First Amended Trust Agreement (the &#147;<B>Existing Trust Agreement</B>&#148;) shall be amended, restated and
replaced by the Second Amended and Restated Trust Agreement attached hereto as <B><U>Exhibit B</U></B> (the &#147;<B>Amended NARCO Asbestos Trust Agreement</B>&#148;). A redline showing the changes the Parties made to the Existing Trust Agreement
pursuant to this Agreement is attached hereto as <B><U>Exhibit BB</U></B>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The North American Refractories Company
Asbestos Personal Injury Settlement Trust Bylaws (the &#147;<B>Existing Bylaws</B>&#148;) shall be amended, restated and replaced by the &#147;North American Refractories Company Asbestos Personal Injury Settlement Trust Amended and Restated
Bylaws&#148; attached hereto as <B><U>Exhibit C</U></B> (the &#147;<B>Amended NARCO Asbestos Trust Bylaws</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Amended NARCO Asbestos TDP, the Amended NARCO Asbestos Trust Agreement, and the
Amended NARCO Asbestos Trust Bylaws (collectively referred to hereinafter as the &#147;<B>Amended Agreements</B>&#148;), shall become automatically and immediately effective as of the Closing, without the need for further action or notice of any
kind and thereupon, the Existing Agreements (as defined below) shall be terminated in all respects, without the need for further action or notice of any kind. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Existing TDP, the Existing Trust Agreement, and the Existing Bylaws (collectively referred to hereinafter as the &#147;<B>Existing
Agreements</B>&#148;), shall continue in effect until the Amended Agreements become effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Parties acknowledge that the
changes made to the Existing Agreements as reflected in the Amended Agreements are material terms to this Agreement, are a material part of the consideration for the promises and undertakings contemplated herein (including the payment of the Buyout
Amount and the releases received herein), and are hereby incorporated into this Agreement by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Subject to the conditions to
the Closing set forth in this Agreement<U>,</U> each Party acknowledges and agrees that its signature pages to each of the applicable Amended Agreements have been irrevocably delivered to the other Parties on the Agreement Date, and that each such
signature page shall be deemed executed and delivered at the Closing, without the need for any further action or notice by such Party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) As soon as practicable following the Closing, the NARCO Asbestos Trust shall post the Amended NARCO Asbestos TDP on the NARCO Asbestos
Trust website. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The Parties acknowledge that notwithstanding anything to the contrary in the NARCO Asbestos Trust Claims Audit
Program, effective April&nbsp;6, 2017 (as may be modified from time to time, the &#147;<B><U>CAP</U></B>&#148;) or the NARCO Asbestos Trust Alternative Dispute Resolution Procedures for NARCO Asbestos Trust Claims, effective August&nbsp;1, 2017 (as
may be modified from time to time, the &#147;<B><U>ADR Procedures</U></B>&#148;), or any other ancillary NARCO Asbestos Trust procedures, following the Closing, Honeywell shall not have any consent, consult, notice or other rights or obligations
under the CAP, the ADR Procedures or any other ancillary NARCO Asbestos Trust procedures. For avoidance of doubt, this <U>Section</U><U></U><U>&nbsp;4(g) </U>shall not limit the Parties&#146; obligations under <U>Section</U><U></U><U>&nbsp;9(c)</U>
of this Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Closing. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Closing Statement</U>. At least five (5)&nbsp;Business Days prior to the Closing, the NARCO Asbestos Trust shall deliver to Honeywell a
statement (the &#147;<B>Closing Statement</B>&#148;) setting forth the Buyout Amount (with reasonable supporting detail showing the calculation of the Buyout Amount, HWI Net Sale Proceeds received by the NARCO Asbestos Trust in cash prior to Closing
(if any), HWI Transaction Fees (if any), NARCO HWI Taxes (if any), Unpaid Claims Amount, as applicable) and the applicable bank account details for the payment of the Buyout Amount. Honeywell shall be permitted to dispute the determination of the
amount of the Buyout Amount, HWI Net Sale Proceeds received by the NARCO Asbestos Trust in cash prior to the Closing, HWI Transaction Fees, NARCO HWI Taxes, and Unpaid Claims Amount set forth in the Closing Statement, and, in the event of any such
dispute, the Parties shall resolve such dispute in accordance with the Review and Dispute Procedures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Closing</U>. The closing of the transactions contemplated by <U>Sections 2</U> and
<U>4</U> (the &#147;<B>Closing</B>&#148;) shall take place as promptly as practicable following January&nbsp;1, 2023, and following the satisfaction or waiver (to the extent permitted by Law) of the conditions set forth in Section&nbsp;6 (other than
those conditions that by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions at such time). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Conditions Precedent. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>General Conditions</U>. The respective obligations of the Parties to effect the Closing are subject to the satisfaction (or waiver, if
permissible under applicable Law) on or prior to the Closing of the following conditions: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) the Delaware Trustee has
executed, and delivered its signature on the Amended NARCO Asbestos Trust Agreement (<B><U>Exhibit B</U></B>); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) the
NARCO Asbestos Trust shall have filed the Approval Motion with the Bankruptcy Court by no later than November&nbsp;18, 2022 seeking approval of this Agreement and the related Amended Agreements, together with supporting declarations from the Parties
and experts attesting to the good faith negotiations leading to this Agreement and that the Buyout Amount is fair and reasonable in all respects and is reasonably likely to put the NARCO Asbestos Trust in a financial position to pay all claimants
the full liquidated value of their claims and to continue to value and pay similar claims in substantially the same manner, in form and substance acceptable to all Parties; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) the Bankruptcy Court shall have entered an order approving the Approval Motion and this Agreement, including without
limitation, the Amended NARCO Asbestos Trust Agreement, and the Amended NARCO Asbestos TDP, all in forms consistent with the forms attached to the Approval Motion, with such modifications as may be acceptable to all Parties and without change or
modification of the Channeling Injunction in any way, which shall be a Final Order (the &#147;<B>Court Approval</B>&#148;); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) no Law, injunction, judgment or ruling (whether preliminary, temporary or permanent) enacted, promulgated, issued,
entered, amended or enforced by a court of competent jurisdiction shall be in effect enjoining, restraining, preventing or prohibiting the consummation of the transactions contemplated by this Agreement or making the consummation of the transactions
contemplated by this Agreement illegal; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) each of the NARCO Asbestos TAC and the FCR has executed, and delivered its
signature on this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Conditions to Obligations of Honeywell</U>. The obligations of Honeywell to effect the transactions
contemplated hereby are subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to the Closing of the following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The representations and warranties of each <FONT STYLE="white-space:nowrap">Non-Honeywell</FONT> Party contained in this
Agreement shall be true and correct in all respects on and as of the Closing, in each case as though such warranties and representations were made at and as of such date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Each <FONT STYLE="white-space:nowrap">Non-Honeywell</FONT> Party shall
have performed and complied in all material respects with all agreements and covenants contained in this Agreement which are required to be performed or complied with by such <FONT STYLE="white-space:nowrap">Non-Honeywell</FONT> Party prior to or at
the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Conditions to Obligations of <FONT STYLE="white-space:nowrap">Non-Honeywell</FONT> Parties</U>. The obligations of
the <FONT STYLE="white-space:nowrap">Non-Honeywell</FONT> Parties to effect the transactions contemplated hereby are subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to the Closing of the following conditions:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The representations and warranties of Honeywell contained in this Agreement shall be true and correct in all material
respects on and as of the Closing, in each case as though such warranties and representations were made at and as of such date; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Honeywell shall have performed and complied in all material respects with all agreements and covenants contained in this
Agreement which are required to be performed or complied with by Honeywell prior to or at the Closing. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Representations. </B></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Each of the Parties hereto represents and warrants to the other Parties that (i)&nbsp;such Party has the requisite power, authority, and
capacity to execute, deliver, and perform its obligations under this Agreement and the Amended Agreements and to consummate the transactions contemplated hereby and thereby, (ii)&nbsp;the execution, delivery, and performance of this Agreement and
each of the Amended Agreements and the consummation of the transactions contemplated hereby and thereby by such Party have been duly and validly authorized by all necessary actions in respect thereof, (iii)&nbsp;this Agreement and the Amended
Agreements have been duly executed and delivered by such Party and, assuming the due execution and delivery by the other parties hereto and thereto, this Agreement constitutes, and the Amended Amendments constitute, valid and binding obligations of
such Party (to the extent applicable), enforceable against such Party in accordance with its and their terms, except as the enforceability hereof or thereof may be limited by any applicable bankruptcy, insolvency, reorganization, moratorium, or
other similar laws affecting the enforcement of creditor&#146;s rights generally and as limited by the availability of specific performance and other equitable remedies or applicable equitable principles, and (iv)&nbsp;the execution, delivery, and
performance of this Agreement and the Amended Agreements and the consummation of the transactions contemplated hereby and thereby by such Party do not violate any governing documents of such Party, or any covenants or other restrictions placed upon
such Party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each of the Parties represents and warrants to the other Parties that (i)&nbsp;such Party has conducted its own
investigation and review of the transactions contemplated by this Agreement, including but not limited to the Buyout Amount and the payment of the Buyout Amount to the NARCO Asbestos Trust, (ii)&nbsp;such Party has come to its own determination,
with the assistance of such Party&#146;s advisors, consultants and experts, that the transactions contemplated by this Agreement are fair and reasonable in all respects and, with respect to the <FONT STYLE="white-space:nowrap">non-Honeywell</FONT>
Parties, the Buyout Amount is reasonably likely to put the NARCO Asbestos Trust in a financial position to pay all claimants the full liquidated value of their claims and to continue to value and pay similar claims in substantially the same manner,
and (iii)&nbsp;such Party is not relying on any other Party or any other Party&#146;s agents in connection with the determinations or matters referred to in <U>Sections 7(b)(i)</U> and <U>7(b)(ii)</U> above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Honeywell represents and warrants to each
<FONT STYLE="white-space:nowrap">non-Honeywell</FONT> Party that (i)&nbsp;as of the Agreement Date, Honeywell has available to it or has the ability to obtain, and at the Closing, Honeywell will have available to it, on an unconditional basis, the
financial capability and adequate unrestricted cash on hand necessary and sufficient to pay the Buyout Amount and (ii)&nbsp;it is not a condition to Closing, or to any of its other obligations under this Agreement, that Honeywell (A)&nbsp;obtain
financing for the transactions contemplated by this Agreement, or (B)&nbsp;reach any other agreement with any third party, including but not limited to Honeywell&#146;s insurers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The NARCO Asbestos Trust represents and warrants to the other Parties that (i)&nbsp;the NARCO Asbestos Trusts is the record and beneficial
owner of, and has good and valid title to, 790 shares of common stock, par value $0.01, of HWI, free and clear of any liens, other than as set forth in the HWI Governance Documents, the Cooperation Agreement and restrictions on transfer arising
under applicable securities laws, and (ii)&nbsp;none of the HWI Interest is subject to any voting trust or other agreement, arrangement or restriction with respect to the voting or the transfer of the HWI Interest, except as set forth in this
Agreement, the Cooperation Agreement or in the HWI Governance Documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>8.</B> <B>Releases.</B> The following releases, which are
provided in consideration for the promises and undertakings contemplated in this Agreement (including the payment of the Buyout Amount and the releases received herein), shall become effective as of the Closing: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <U>Release of Honeywell</U>: The NARCO Asbestos Trust, the NARCO Asbestos TAC, each Trustee of the NARCO Asbestos Trust, each member of
the NARCO Asbestos TAC, and the FCR, in each case solely in their official capacities relating to the NARCO Asbestos Trust, and on behalf of each of their respective current, former or future entities, subsidiaries, parent companies, divisions,
organizations, members, firms, equity holders, shareholders, interest holders, directors, officers, managers, employees, trustees, estates, fiduciaries, partners, partnerships, joint ventures, limited liability companies, corporations, affiliates,
attorneys, accountants, auditors, agents, advisors, consultants, investment bankers, insurers, experts, underwriters, brokers, dealers, lenders, commercial bankers, claim processors, other representatives, predecessors, successors and assigns, or
affiliates, direct and indirect, or persons under common control with any of the foregoing, and all persons acting by, through, under, or in concert with them (but for the avoidance of doubt, not on behalf of any holders of NARCO Asbestos Trust
Claims, whose treatment remains consistent with the Confirmation Order and Channeling Injunction) (collectively, the &#147;<B><FONT STYLE="white-space:nowrap">Non-Honeywell</FONT> Releasors</B>&#148;), hereby release, acquit, and forever discharge
Honeywell, and each case in its official capacity relating to the NARCO Asbestos Trust, and each of its respective current, former or future entities, subsidiaries, parent companies, divisions, organizations, members, firms, equity holders,
shareholders, interest holders, directors, officers, managers, employees, trustees, estates, fiduciaries, partners, partnerships, joint ventures, limited liability companies, corporations, affiliates, attorneys, accountants, auditors, agents,
advisors, consultants, investment bankers, insurers, experts, underwriters, brokers, dealers, lenders, commercial bankers, claim processors, other representatives, predecessors, successors and assigns, or affiliates, direct and indirect, or persons
under common control with any of the foregoing, and all persons acting by, through, under, or in concert with Honeywell, including without limitation, Honeywell&#146;s past or present representatives on the HWI Board (collectively, the
&#147;<B>Honeywell Released Parties</B>&#148;), from any and all known and unknown charges, complaints, claims, grievances, liabilities, obligations, promises, agreements, controversies, damages, actions, causes of action, suits, rights, demands,
costs, losses, debts, penalties, fees, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
counterclaims, sums of money, accounts, contracts, contribution, indemnification, damages, assessments, judgments, executions, and punitive damages, of any nature whatsoever, at law, in equity or
otherwise, which the <FONT STYLE="white-space:nowrap">Non-Honeywell</FONT> Releasors, or any of them, now or hereafter can, shall, or may have in the future against the Honeywell Released Parties, or any of them, whether known or unknown, whether or
not apparent yet or yet to be discovered, or which may hereafter develop, in any way relating to or arising out of the NARCO Asbestos Trust, the administration of the NARCO Asbestos Trust, any Trust Agreement that was operative prior to the Closing
including without limitation the Existing Trust Agreement, any TDP that was operative prior to the Closing including without limitation the Existing TDP, the Honeywell Obligations, the Plan, the Cooperation Agreement, HWI (and its predecessors), any
actual or attempted HWI Sale, the participation of Honeywell&#146;s current, former or future representatives on the HWI Board, any obligations under any agreements (other than this Agreement) or judicial decrees or orders (other than any court
orders related to this Agreement) imposing any obligations on Honeywell related to the NARCO Asbestos Trust, all from the beginning of time through the Closing; <U>provided</U>, <U>however</U>, that nothing herein (i)&nbsp;modifies, dissolves,
terminates, or affects in any manner the NARCO Channeling Injunction, or (ii)&nbsp;releases or affects any obligations of the Honeywell Released Parties contained in this Agreement or in the Confidentiality Agreement that Honeywell, the NARCO
Asbestos Trust, and McDermott Will&nbsp;&amp; Emery entered as of November&nbsp;20, 2014, as amended (the &#147;<B>Existing Confidentiality Agreement</B>&#148;), subject to <U>Section</U><U></U><U>&nbsp;9(c)</U> of this Agreement. For the avoidance
of doubt, at the Closing, the Cooperation Agreement and the Existing Agreements shall be terminated in all respects without further action of any kind, and the Honeywell Released Parties shall have no liabilities or further obligations in connection
therewith to the <FONT STYLE="white-space:nowrap">Non-Honeywell</FONT> Releasors, all such liabilities or obligations having been released and terminated under the above release. For the further avoidance of doubt, nothing herein shall release the
Honeywell Released Parties from any claims arising from conduct or events occurring after the Closing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Release of the Trust</U>:
Honeywell, the NARCO Asbestos TAC, each member of the NARCO Asbestos TAC, and the FCR, on behalf of themselves and on behalf of each of their respective current, former or future entities, subsidiaries, parent companies, divisions, organizations,
members, firms, equity holders, shareholders, interest holders, directors, officers, managers, employees, trustees, estates, fiduciaries, partners, partnerships, joint ventures, limited liability companies, corporations, affiliates, attorneys,
accountants, auditors, agents, advisors, consultants, investment bankers, insurers, experts, underwriters, brokers, dealers, lenders, commercial bankers, claim processors, other representatives, predecessors, successors and assigns, or affiliates,
direct and indirect, or persons under common control with any of the foregoing, and all persons acting by, through, under, or in concert with them (collectively, the &#147;<B><FONT STYLE="white-space:nowrap">Non-Trust</FONT> Releasors</B>&#148;),
hereby release, acquit, and forever discharge the NARCO Asbestos Trust and each Trustee of the NARCO Asbestos Trust, in their official capacities relating to the NARCO Asbestos Trust, and each of their respective current, former or future entities,
subsidiaries, parent companies, divisions, organizations, members, firms, equity holders, shareholders, interest holders, directors, officers, managers, employees, trustees, estates, fiduciaries, partners, partnerships, joint ventures, limited
liability companies, corporations, affiliates, attorneys, accountants, auditors, agents, advisors, consultants, investment bankers, insurers, experts, underwriters, brokers, dealers, lenders, commercial bankers, claim processors, other
representatives, predecessors, successors and assigns, or affiliates, direct and indirect, or persons under common control with any of the foregoing, and all persons acting by, through, under, or in concert with them (but for the avoidance of doubt,
not on behalf of any holders of NARCO Asbestos Trust Claims) (collectively, the &#147;<B>Trust Released Parties</B>&#148;), from any and all known and unknown charges, complaints, claims, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
grievances, liabilities, obligations, promises, agreements, controversies, damages, actions, causes of action, suits, rights, demands, costs, losses, debts, penalties, fees, counterclaims, sums
of money, accounts, contracts, contribution, indemnification, damages, assessments, judgments, executions, and punitive damages, of any nature whatsoever, at law, in equity or otherwise, which the <FONT STYLE="white-space:nowrap">Non-Trust</FONT>
Releasors, or any of them, now or hereafter can, shall, or may have in the future against the Trust Released Parties, or any of them, whether known or unknown, whether or not apparent yet or yet to be discovered, or which may hereafter develop, in
any way relating to or arising out of the NARCO Asbestos Trust, the administration of the NARCO Asbestos Trust, any Trust Agreement that was operative prior to the Closing including without limitation the Existing Trust Agreement, any TDP that was
operative prior to the Closing including without limitation the Existing TDP, the Honeywell Obligations, the Plan, the Cooperation Agreement, HWI (and its predecessors), any actual or attempted HWI Sale, the participation of Honeywell&#146;s
current, former or future representatives on the HWI Board, any obligations under any agreements (other than this Agreement) or judicial decrees or orders (other than any court orders related to this Agreement) imposing any obligations on the NARCO
Asbestos Trust, all from the beginning of time through the Closing; <U>provided</U>, <U>however</U>, that nothing herein (i)&nbsp;modifies, dissolves, terminates, or affects in any manner the NARCO Channeling Injunction, or (ii)&nbsp;releases or
affects any obligations of any of the Trust Released Parties contained in this Agreement or in the Existing Confidentiality Agreement, subject to <U>Section</U><U></U><U>&nbsp;9(c)</U> of this Agreement. For the avoidance of doubt, at the Closing,
the Cooperation Agreement and the Existing Agreements shall be terminated in all respects without further action of any kind, and the Trust Released Parties shall have no liabilities or further obligations in connection therewith to the <FONT
STYLE="white-space:nowrap">Non-Trust</FONT> Releasors, all such liabilities or obligations having been released and terminated under the above release. For the further avoidance of doubt, nothing herein shall release the Trust Released Parties from
any claims arising from conduct or events occurring after the Closing. Nothing herein is intended to release the NARCO Asbestos Trust from the compensation and reimbursement obligations under sections 5.5, 5.6, 6.5 and 7.5 of the Existing Trust
Agreement for amounts accrued and unpaid prior to Closing.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Release of the NARCO Asbestos TAC</U>: Honeywell, the NARCO Asbestos
Trust, each Trustee of the NARCO Asbestos Trust, and the FCR, on behalf of themselves and on behalf of each of their respective current, former or future entities, subsidiaries, parent companies, divisions, organizations, members, firms, equity
holders, shareholders, interest holders, directors, officers, managers, employees, trustees, estates, fiduciaries, partners, partnerships, joint ventures, limited liability companies, corporations, affiliates, attorneys, accountants, auditors,
agents, advisors, consultants, investment bankers, insurers, experts, underwriters, brokers, dealers, lenders, commercial bankers, claim processors, other representatives, predecessors, successors and assigns, or affiliates, direct and indirect, or
persons under common control with any of the foregoing, and all persons acting by, through, under, or in concert with them (collectively, the &#147;<B><FONT STYLE="white-space:nowrap">Non-TAC</FONT> Releasors</B>&#148;), hereby release, acquit, and
forever discharge the NARCO Asbestos TAC and each member of the NARCO Asbestos TAC, in their official capacities relating to the NARCO Asbestos Trust, and each of their respective current, former or future entities, subsidiaries, parent companies,
divisions, organizations, members, firms, equity holders, shareholders, interest holders, directors, officers, managers, employees, trustees, estates, fiduciaries, partners, partnerships, joint ventures, limited liability companies, corporations,
affiliates, attorneys, accountants, auditors, agents, advisors, consultants, investment bankers, insurers, experts, underwriters, brokers, dealers, lenders, commercial bankers, claim processors, other representatives, predecessors, successors and
assigns, or affiliates, direct and indirect, or persons under common control with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
any of the foregoing, and all persons acting by, through, under, or in concert with them (but for the avoidance of doubt, not on behalf of any holders of NARCO Asbestos Trust Claims)
(collectively, the &#147;<B>TAC Released Parties</B>&#148;), from any and all known and unknown charges, complaints, claims, grievances, liabilities, obligations, promises, agreements, controversies, damages, actions, causes of action, suits,
rights, demands, costs, losses, debts, penalties, fees, counterclaims, sums of money, accounts, contracts, contribution, indemnification, damages, assessments, judgments, executions, and punitive damages, of any nature whatsoever, at law, in equity
or otherwise, which the <FONT STYLE="white-space:nowrap">Non-TAC</FONT> Releasors, or any of them, now or hereafter can, shall, or may have in the future against the TAC Released Parties, or any of them, whether known or unknown, whether or not
apparent yet or yet to be discovered, or which may hereafter develop, in any way relating to or arising out of the NARCO Asbestos Trust, the administration of the NARCO Asbestos Trust, any Trust Agreement that was operative prior to the Closing
including without limitation the Existing Trust Agreement, any TDP that was operative prior to the Closing including without limitation the Existing TDP, the Honeywell Obligations, the Plan, the Cooperation Agreement, HWI (and its predecessors), any
actual or attempted HWI Sale, the participation of Honeywell&#146;s current, former or future representatives on the HWI Board, any obligations under any agreements (other than this Agreement) or judicial decrees or orders (other than any court
orders related to this Agreement) imposing any obligations on the NARCO Asbestos TAC, all from the beginning of time through the Closing; <U>provided</U>, <U>however</U>, that nothing herein (i)&nbsp;modifies, dissolves, terminates, or affects in
any manner the NARCO Channeling Injunction, or (ii)&nbsp;releases or affects any obligations of any of the TAC Released Parties contained in this Agreement or in the Existing Confidentiality Agreement, subject to
<U>Section</U><U></U><U>&nbsp;9(c)</U> of this Agreement. For the avoidance of doubt, at the Closing, the Existing Agreements shall be terminated in all respects without further action of any kind, and the TAC Released Parties shall have no
liabilities or further obligations in connection therewith to the <FONT STYLE="white-space:nowrap">Non-TAC</FONT> Releasors, all such liabilities or obligations having been released and terminated under the above release. For the further avoidance
of doubt, nothing herein shall release the TAC Released Parties from any claims arising from conduct or events occurring after the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Release of the FCR</U>: Honeywell, the NARCO Asbestos Trust, each Trustee of the NARCO Asbestos Trust, the NARCO Asbestos TAC, and each
member of the NARCO Asbestos TAC, on behalf of themselves and on behalf of each of their respective current, former or future entities, subsidiaries, parent companies, divisions, organizations, members, firms, equity holders, shareholders, interest
holders, directors, officers, managers, employees, trustees, estates, fiduciaries, partners, partnerships, joint ventures, limited liability companies, corporations, affiliates, attorneys, accountants, auditors, agents, advisors, consultants,
investment bankers, insurers, experts, underwriters, brokers, dealers, lenders, commercial bankers, claim processors, other representatives, predecessors, successors and assigns, or affiliates, direct and indirect, or persons under common control
with any of the foregoing, and all persons acting by, through, under, or in concert with them (collectively, the &#147;<B><FONT STYLE="white-space:nowrap">Non-FCR</FONT> Releasors</B>&#148;), hereby release, acquit, and forever discharge the FCR, in
his official capacity relating to the NARCO Asbestos Trust, and each of the FCR&#146;s respective current, former or future entities, subsidiaries, parent companies, divisions, organizations, members, firms, equity holders, shareholders, interest
holders, directors, officers, managers, employees, trustees, estates, fiduciaries, partners, partnerships, joint ventures, limited liability companies, corporations, affiliates, attorneys, accountants, auditors, agents, advisors, consultants,
investment bankers, insurers, experts, underwriters, brokers, dealers, lenders, commercial bankers, claim processors, other representatives, predecessors, successors and assigns, or affiliates, direct and indirect, or persons under common control
with any of the foregoing, and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
all persons acting by, through, under, or in concert with them (but for the avoidance of doubt, not on behalf of any holders of NARCO Asbestos Trust Claims) (collectively, the &#147;<B>FCR
Released Parties</B>&#148;), from any and all known and unknown charges, complaints, claims, grievances, liabilities, obligations, promises, agreements, controversies, damages, actions, causes of action, suits, rights, demands, costs, losses, debts,
penalties, fees, counterclaims, sums of money, accounts, contracts, contribution, indemnification, damages, assessments, judgments, executions, and punitive damages, of any nature whatsoever, at law, in equity or otherwise, which the <FONT
STYLE="white-space:nowrap">Non-FCR</FONT> Releasors, or any of them, now or hereafter can, shall, or may have in the future against the FCR Released Parties, or any of them, whether known or unknown, whether or not apparent yet or yet to be
discovered, or which may hereafter develop, in any way relating to or arising out of the NARCO Asbestos Trust, the administration of the NARCO Asbestos Trust, any Trust Agreement that was operative prior to the Closing including without limitation
the Existing Trust Agreement, any TDP that was operative prior to the Closing including without limitation the Existing TDP, the Honeywell Obligations, the Plan, the Cooperation Agreement, HWI (and its predecessors), any actual or attempted HWI
Sale, the participation of Honeywell&#146;s current, former or future representatives on the HWI Board, any obligations under any agreements (other than this Agreement) or judicial decrees or orders (other than any court orders related to this
Agreement) imposing any obligations on the FCR, all from the beginning of time through the Closing; <U>provided</U>, <U>however</U>, that nothing herein (i)&nbsp;modifies, dissolves, terminates, or affects in any manner the NARCO Channeling
Injunction, or (ii)&nbsp;releases or affects any obligations of any of the FCR Released Parties contained in this Agreement or in the Existing Confidentiality Agreement, subject to <U>Section</U><U></U><U>&nbsp;9(c)</U> of this Agreement. For the
avoidance of doubt, at the Closing, the Existing Agreements shall be terminated in all respects without further action of any kind, and the FCR Released Parties shall have no liabilities or further obligations in connection therewith to the <FONT
STYLE="white-space:nowrap">Non-FCR</FONT> Releasors, all such liabilities or obligations having been released and terminated under the above release. For the further avoidance of doubt, nothing herein shall release the FCR Released Parties from any
claims arising from conduct or events occurring after the Closing. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>9.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Other Agreements. </B></P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Further Support and Cooperation</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Each Party shall use its reasonable best efforts and shall reasonably cooperate with each other Party (A)&nbsp;to obtain
the Court Approval and/or any other court that must approve the payment of the Buyout Amount, (B)&nbsp;to oppose and defeat any objections to such approval or appeals thereof; (C)&nbsp;oppose and contest any present or future objections to this
Agreement or the transactions contemplated hereby (including but not limited to the Amended Agreements), and (D)&nbsp;to defend any such objections or collateral attacks after the Closing to the approvals provided with respect to the payment of the
Buyout Amount and/or any terms of this Agreement (including but not limited to the Amended Agreements). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) From and
after the Closing, Honeywell shall, and shall cause its representatives and Affiliates to, reasonably cooperate with the NARCO Asbestos Trust and its representatives and advisors in connection with the historical records and reporting obligations
under MMSEA and with respect to <FONT STYLE="white-space:nowrap">Pre-Established</FONT> Claims, as more fully described below, including by (A)&nbsp;making personnel reasonably available during normal business hours for consultations in a manner so
as not to interfere unreasonably with the conduct of Honeywell, and (B)&nbsp;providing the NARCO Asbestos Trust and its advisors and representatives access to such information, documents and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
records in Honeywell&#146;s possession, custody, or control as requested in connection with processing <FONT STYLE="white-space:nowrap">Pre-Established</FONT> Claims and reporting obligations
under MMSEA. Honeywell shall, and shall cause its Affiliates and representatives to, retain any information, documents and records related to the payment, processing and/or reporting with respect to NARCO Asbestos Trust Claims prior to the Closing
for a period of no less than six years after the Closing. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Medicare Obligations</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Parties agree that, on and after the Closing: (A)&nbsp;the NARCO Asbestos Trust shall register as a Responsible
Reporting Entity (&#147;<B>RRE</B>&#148;), in lieu of Honeywell, under the reporting provisions of Section&nbsp;111 of the Medicare, Medicaid, and SCHIP Extension Act of 2007 (Pub. L. <FONT STYLE="white-space:nowrap">110-173)</FONT>
(&#147;<B>MMSEA</B>&#148;); and (B)&nbsp;the NARCO Asbestos Trust will provide the Centers for Medicare and Medicaid Services (&#147;<B>CMS</B>&#148;) with the information necessary for compliance with MMSEA Section&nbsp;111. To be clear, Honeywell
shall remain wholly responsible for errors and/or failure in reporting any claim required to be reported to CMS prior to the Closing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) From and after the Agreement Date, Honeywell shall take all reasonable and necessary steps to support the NARCO Asbestos
Trust&#146;s compliance with Section&nbsp;3.6 of the Amended NARCO Asbestos Trust Agreement, including, but not limited to (A)&nbsp;if requested by the NARCO Asbestos Trust, using commercially reasonable efforts to assign its rights and obligations
(solely to the extent arising after the Closing) under any agreements with third party providers Honeywell has contracted with to comply with such reporting requirements and solely to the extent assignment is permitted under any such agreement(s),
and (B)&nbsp;providing the NARCO Asbestos Trust with copies of all records of historical MMSEA reporting related to NARCO Asbestos Trust Claims in Honeywell&#146;s possession. For the avoidance of doubt, Honeywell shall continue reporting to CMS
until the later of Closing or the NARCO Asbestos Trust&#146;s receipt of permission from CMS to report as the RRE with respect to NARCO Asbestos Trust Claims. If pursuant to this provision, Honeywell must continue reporting to CMS after the Closing,
the NARCO Asbestos Trust shall provide Honeywell with information available to the NARCO Asbestos Trust necessary to comply with MMSEA Section&nbsp;111 for so long as Honeywell must continue reporting to CMS. Honeywell shall keep any information and
documents received from the NARCO Asbestos Trust pursuant to this Section&nbsp;9(b)(ii) confidential and shall not use such information for any purpose other than meeting obligations under MSPA and/or MMSEA. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The NARCO Asbestos Trust shall provide Honeywell with information available to the NARCO Asbestos Trust necessary to
comply with MMSEA Section&nbsp;111 in the event subsequent law, final regulations or binding CMS requirements prohibit the NARCO Asbestos Trust from reporting as the RRE or acting as the reporting agent on behalf of the RRE with respect to NARCO
Asbestos Trust Claims, with any and all expenses related thereto to be borne solely by the NARCO Asbestos Trust. Honeywell shall keep any information and documents received from the NARCO Asbestos Trust pursuant to this Section&nbsp;9(b)(iii)
confidential and shall not use such information for any purpose other than meeting obligations under MSPA and/or MMSEA. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) The NARCO Asbestos Trust further agrees that, to the extent that some
or all of the payment that Honeywell makes to the NARCO Asbestos Trust under this Agreement is used to fund settlements of NARCO Asbestos Trust Claims that potentially implicate 42 U.S.C. 1395y(b) of the Medicare Secondary Payor Act and the rules
and regulations promulgated thereunder (collectively &#147;<B>MSP</B>&#148;), on or after the Closing, the NARCO Asbestos Trust shall obtain prior to remittance of funds to claimants&#146; counsel or to the claimant, if pro se, in respect of any
NARCO Asbestos Trust Claim a certification from the claimant to be paid that said claimant has or will provide for the payment and/or resolution of any obligations owing or potentially owing under 42 U.S.C. &#167; 1395y(b), or any related rules,
regulations, or guidance, in connection with, or relating to, such NARCO Asbestos Trust Claim.&nbsp;This certification may be contained in the claimant&#146;s release of the NARCO Asbestos Trust executed in connection with payment of the claim. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Insurance Information</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Insurance Purposes</I>.&nbsp;On and after the Closing, a third-party insurance administrator retained by Honeywell
(&#147;<B>Honeywell</B><B>&#146;</B><B>s TPA</B>&#148;), currently anticipated to be The Claro Group LLC, shall have access to (A)&nbsp;on a quarterly basis, for all NARCO Asbestos Trust Claims, aggregate information on the total number of filed,
pending, and settled claims by disease type, and (B)&nbsp;solely with respect to any NARCO Asbestos Trust Claims that are paid by the NARCO Asbestos Trust (&#147;<B>Paid Claims</B>&#148;) on a monthly basis, the NARCO Asbestos Trust&#146;s paid
claims database in SQL or a substantially similar database format (hereinafter, &#147;<B>Paid Claims Database</B>&#148;), and (C)&nbsp;no more frequently than monthly, Paid Claims files containing the documentation substantiating exposure and date
of first exposure to a NARCO asbestos containing product, asbestos disease, the release, and any other documentation relating to the Paid Claims that the NARCO Asbestos Trust gathered or received for the purpose of making payments to such claimants
(collectively (A), (B) and (C), &#147;<B>Trust Claims Data</B>&#148;), such access in a manner to be reasonably agreed between the NARCO Asbestos Trust and Honeywell&#146;s TPA and subject to the Existing Confidentiality Agreement other than
sections 4(b), 4(c) and 7 thereof, and any exceptions for &#147;Medicare Obligations&#148; contained therein which sections and exceptions shall have no further force and effect on and after the Closing. On and after the Closing, Trust Claims Data
accessed pursuant to this Section&nbsp;9(c) may only be used to report and recover under Honeywell&#146;s insurance policies applicable to NARCO and under settlement agreements that Honeywell has entered or enters with its insurers for NARCO
Asbestos Claims (such purposes hereinafter, the &#147;<B>NARCO</B> <B>Insurance Purposes</B>&#148;). Specifically, Honeywell&#146;s TPA shall, at Honeywell&#146;s sole expense, be entitled to request, receive, review and utilize Trust Claims Data
solely for NARCO Insurance Purposes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) <I>Confidentiality</I>.&nbsp;On and after the Closing, Honeywell&#146;s TPA and
Honeywell&#146;s insurance coverage counsel (with which Honeywell&#146;s TPA may share Trust Claims Data and information provided pursuant to subsection (iii)&nbsp;below) shall maintain the confidentiality of such Trust Claims Data under the
Existing Confidentiality Agreement, subject to the modifications set forth above, and as may be subsequently amended including subsequent to this Agreement. The scope of Honeywell&#146;s TPA&#146;s permitted use of Trust Claims Data for NARCO
Insurance Purposes shall include Honeywell&#146;s TPA providing Trust Claims Data to Honeywell&#146;s insurers that have entered an insurer confidentiality agreement with the NARCO Asbestos Trust or that is acceptable to the NARCO Asbestos Trust
(hereinafter, &#147;<B>Trust Insurer Confidentiality Agreement</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) <I>Scope of Honeywell&#146;s TPA&#146;s Access To Cost Data. </I>On a
quarterly basis, the NARCO Asbestos Trust will provide Honeywell&#146;s TPA unaudited and summary level paid cost information by cost category.<I> </I>In addition, only upon receiving a request from a Honeywell insurer that has entered into a Trust
Insurer Confidentiality Agreement, Honeywell&#146;s TPA may request and shall receive from the NARCO Asbestos Trust (A)&nbsp;claims-related service provider invoices submitted to the NARCO Asbestos Trust and (B)&nbsp;summary level paid cost
information by vendor. The NARCO Asbestos Trust may redact such invoices to avoid disclosure of any claimant data, attorney-client privileged communications and attorney opinion work product. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) <I>Reasonable Cooperation</I>.&nbsp;On and after the Closing, the NARCO Asbestos Trust shall reasonably cooperate (at
Honeywell&#146;s sole cost and expense) with Honeywell&#146;s TPA in connection with any reasonable inquiry that Honeywell&#146;s TPA makes for NARCO Insurance Purposes, including requests for additional Trust Claims Data and/or clarification of
Trust Claims Data that the NARCO Asbestos Trust has previously provided to Honeywell&#146;s TPA regarding Paid Claims. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)
<I>Costs</I>.<I> </I>The cost of the Trust&#146;s performance under this section 9(c) shall be at the sole expense of Honeywell. Honeywell shall, at the NARCO Asbestos Trust&#146;s request, promptly advance funds to the NARCO Asbestos Trust for
documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by the NARCO Asbestos Trust in connection with this Section&nbsp;9(c). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) <I>Termination of Insurance Reporting. </I>If Honeywell no longer has reporting obligations to any insurer, then Honeywell
shall promptly notify the NARCO Asbestos Trust in writing and all obligations of the NARCO Asbestos Trust under this Section&nbsp;9(c) shall cease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U><FONT STYLE="white-space:nowrap">Pre-Established</FONT> Claims</U>. Prior to the Closing, Honeywell shall provide the NARCO Asbestos
Trust with all of the information, historical records, documents and databases reasonably necessary to process <FONT STYLE="white-space:nowrap">Pre-Established</FONT> Claims as set forth in the Amended Agreements, including, but not limited to,
Section&nbsp;4.2 of the Amended NARCO Asbestos TDP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Auditor Access</U>. Notwithstanding anything contrary in this
<U>Section</U><U></U><U>&nbsp;9</U>, on and after the Closing, the NARCO Asbestos Trust shall reasonably cooperate (at Honeywell&#146;s sole cost and expense) with Honeywell&#146;s auditor in connection with any reasonable inquiry that
Honeywell&#146;s auditor makes for purposes of conducting an integrated audit of (A)&nbsp;Honeywell&#146;s NARCO-related insurance receivables or (B)&nbsp;for a period of seven years from the Closing, Honeywell&#146;s NARCO-related
liabilities.&nbsp;Such reasonable inquiry may include requests for Trust Claims Data, Paid Claims Database, summary level paid cost information by vendor and/or by cost category, and NARCO Asbestos Trust claims-related service provider invoices
submitted to the NARCO Asbestos Trust.&nbsp;The NARCO Asbestos Trust may redact such invoices to avoid disclosure of any claimant data, attorney-client privileged communications and attorney opinion work product. When neither Honeywell nor its
auditor has continuing reporting obligations with respect to the NARCO Asbestos Trust, then Honeywell shall promptly notify the NARCO Asbestos Trust in writing and all obligations of the NARCO Asbestos Trust under this Section&nbsp;9(e) shall cease.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>10. Termination. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) This Agreement may be terminated at any time prior to the Closing: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) By the mutual written consent of the Parties; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) By Honeywell or the NARCO Asbestos Trust if Court Approval is not capable of being obtained; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) By Honeywell, if Honeywell is not in material breach of its obligations under this Agreement and the <FONT
STYLE="white-space:nowrap">Non-Honeywell</FONT> Parties fail to comply in any material respect with their covenants or agreements contained herein, or breach their representations and warranties contained herein in any material respect and such
failure or breach, is not cured within thirty (30)&nbsp;days of the receipt of written notice of such failure or breach from Honeywell; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) By the NARCO Asbestos Trust if the <FONT STYLE="white-space:nowrap">Non-Honeywell</FONT> Parties are not in material
breach of their obligations under this Agreement and Honeywell fails to comply in any material respect with its covenants or agreements contained herein, or breaches its representations and warranties contained herein in any material respect and
such failure or breach, is not cured within thirty (30)&nbsp;days of the receipt of written notice of such failure or breach from NARCO Asbestos Trust. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) This Agreement will automatically terminate on March&nbsp;31, 2023 unless (x)&nbsp;the Closing occurs prior to such date, or
(y)&nbsp;Honeywell and the NARCO Asbestos Trust mutually agree to extend this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In the event of the termination of this
Agreement as provided in <U>Section</U><U></U><U>&nbsp;10(a)</U>, written notice thereof shall be given to the other Parties to this Agreement specifying the provision of this Agreement pursuant to which such termination is made, and this Agreement
shall forthwith become null and void (other than the provisions of this <U>Section</U><U></U><U>&nbsp;10(c)</U> and <U>Section</U><U></U><U>&nbsp;11</U>), and there shall be no liability on the part of any Party or its directors, officers, trustees
or Affiliates; <U>provided</U>, <U>however</U>, that nothing in this Agreement will relieve any Party from liability for any intentional breach of this Agreement prior to such termination or for fraud. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>11. Miscellaneous. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)
<U>Specific Performance</U>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) Each Party agrees that irreparable damage would occur and that the Parties would not have
any adequate remedy at law in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached. Accordingly, in addition to any other remedies available under this
Agreement, the Parties agree that, prior to a valid termination of this Agreement in accordance with the terms of this Agreement, each Party shall be entitled to an injunction or injunctions, specific performance and other equitable relief, without
proof of actual damages, to prevent each other Party&#146;s breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement (including a Party&#146;s obligation to consummate the transactions contemplated by this
Agreement if required to do so hereunder). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Each Party agrees that it will not oppose the granting of an
injunction, specific performance and other equitable relief when expressly available pursuant to the terms of this Agreement, and hereby waives (A)&nbsp;any defenses in any action for an injunction, specific performance or other equitable relief,
including the defense that the other parties have an adequate remedy at law or an award of specific performance is not an appropriate remedy for any reason at law or equity, and (B)&nbsp;any requirement under Law to post a bond, undertaking or other
security as a prerequisite to obtaining equitable relief. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <U>Governing Law; Submission to Jurisdiction</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) This Agreement, its performance, enforcement, and any disputes relating thereto shall be governed by and construed in
accordance with the internal laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule that would cause the application of laws of any jurisdiction other than those of the State of Delaware. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Any claim or dispute arising out of or relating to this Agreement, its performance, enforcement or otherwise shall be
instituted exclusively in the Bankruptcy Court, and each Party agrees not to assert, by way of motion, as a defense or otherwise, in any such claim or dispute, that it is not subject personally to the jurisdiction of such Bankruptcy Court, that the
claim is brought in an inconvenient forum, that the venue of the claim is improper or that this Agreement or the subject matter hereof may not be enforced in or by such Bankruptcy Court. Each Party further irrevocably submits to the continuing
jurisdiction of such Bankruptcy Court in any such claim or dispute. If such Bankruptcy Court does not accept jurisdiction for any reason, then the exclusive forum and venue and other provisions in this Section will apply to the federal court sitting
in the Western District of Pennsylvania. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <U>Counterparts</U>. This Agreement and its Exhibits may be executed via electronic
signature, in multiple counterparts, each of which shall be deemed an original, and all of which shall constitute one and the same agreement. A signed copy of this Agreement and its Exhibits delivered by
<FONT STYLE="white-space:nowrap">e-mail</FONT> or other means of electronic transmission shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement and its Exhibits. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <U>Agreement is Legally Binding; Beneficiaries; Assignment</U>. This Agreement (including, for the avoidance of doubt,
<U>Section</U><U></U><U>&nbsp;3</U> above) shall be legally binding upon Honeywell and the NARCO Asbestos Trust upon execution by Honeywell and the NARCO Asbestos Trust and shall inure to the benefit of each of them and their respective successors
and assigns. Once executed by all Parties, the Parties intend this Agreement to be legally binding upon and shall inure to the benefit of each of them and their respective successors and assigns. Nothing in this Agreement expressed or implied is
intended or shall be construed to confer upon or give to any person or entity, other than the Parties and their respective permitted successors and assigns, any rights or remedies under or by reason of this Agreement. Neither this Agreement nor any
rights, benefits, or obligations set forth herein may be assigned by any of the Parties without the prior written consent of each of the other Parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <U>Severability</U>. Except as set forth otherwise in connection with the requirements relating to Court Approval and any appeals thereof,
(i)&nbsp;the provisions of this Agreement shall be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof, (ii)&nbsp;if any provision of this Agreement,
or the application thereof to any person or any circumstance, is invalid or unenforceable, (x)&nbsp;a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent and
purpose of such invalid or unenforceable provision, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and (y)&nbsp;the remainder of this Agreement and the application of such provision to other persons or circumstances shall not be affected by such invalidity or unenforceability, nor shall such
invalidity or unenforceability affect the validity or enforceability of such provision, or the application thereof, in any other jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <U>No Admissions</U>. Nothing in this Agreement may be construed as evidence of any admission by any of the Parties of the validity of any
of the claims, liabilities, losses, demands, or damages of any nature or kind asserted or that could be asserted against any other Party, its liability therefor, or of any wrongdoing on its part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <U>Amendment</U>. This Agreement or any portion thereof may be waived, amended, or modified only by a written agreement signed by an
authorized signatory of all Parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <U>Entire Agreement</U>. This Agreement (together with each of the Exhibits thereto) constitutes
the complete and final understanding among the Parties with regard to the subject matter hereof and supersedes and cancels all prior or contemporaneous agreements regarding the subject matter hereof. In the event of any inconsistency between the
statements in the body of this Agreement and the Exhibits hereto, the statements in the body of this Agreement shall control. This Agreement is entered into by the Parties with full knowledge of any and all rights that the Parties may have. All
Parties have received independent legal advice, have conducted such investigation as each of them and their counsel determined is appropriate, and have consulted with such other independent advisors as each of them and their counsel deemed
appropriate regarding this Agreement and the rights and asserted rights in connection with this Agreement. In the event of any inconsistency, conflict or discrepancy between the terms of this Agreement and the terms of the Amended Agreements, the
terms of this Agreement shall control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <U>Notices</U>. All notices and other communications required by this Agreement shall be in
writing and shall be deemed to have been given (a)&nbsp;when delivered by hand, (b)&nbsp;when received by the addressee if sent by a nationally recognized overnight courier (return receipt requested), (c) on the date sent by <FONT
STYLE="white-space:nowrap">e-mail</FONT> or facsimile (without receipt of a &#147;bounceback&#148; or other notice of <FONT STYLE="white-space:nowrap">non-delivery)</FONT> if sent during normal business hours of the recipient or on the next Business
Day if sent after normal business hours of the recipient, or (d)&nbsp;on the third day after the date mailed, by certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent to the applicable Party, at
the following address or <FONT STYLE="white-space:nowrap">e-mail</FONT> address (or at such other address or <FONT STYLE="white-space:nowrap">e-mail</FONT> address as shall be specified for such purpose in a notice given in accordance with this
Section): </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To Honeywell: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Honeywell International Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">855
South Mint Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Charlotte, NC 28202 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: Lynn A. Dummett </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email:
lynn.dummett@honeywell.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Kirkland&nbsp;&amp; Ellis LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">601 Lexington Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York,
NY 10022 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: Nicole L. Greenblatt </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: nicole.greenblatt@kirkland.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To the NARCO Asbestos Trust: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Hon. Ken M. Kawaichi (Ret.) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">14
Mesa Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Piedmont, California 94611 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile: (510) <FONT STYLE="white-space:nowrap">601-9254</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: k.m.kawaichi@gmail.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Richard B. Schiro </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">3710 Rawlins
Street, Suite 1350 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Dallas, Texas 75219 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile: (214) <FONT STYLE="white-space:nowrap">521-3838</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: rbschiro@schirolaw.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Mark M. Gleason&nbsp;&amp; Associates </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">One Gateway Center, Suite 525 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">420 Fort Duquesne Blvd. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Pittsburgh, PA 15222-1402 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile: (412) <FONT STYLE="white-space:nowrap">391-1790</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: mgleason@gleasonexperts.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Sander L. Esserman </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Steven A.
Felsenthal </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Stutzman, Bromberg, Esserman&nbsp;&amp; Plifka </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">2323 Bryan Street, Suite 2200 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Dallas, Texas 75201 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile:
(214) <FONT STYLE="white-space:nowrap">969-4999</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: <FONT STYLE="white-space:nowrap">Esserman@sbep-law.com</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: <FONT STYLE="white-space:nowrap">Felsenthal@sbep-law.com</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Willkie Farr&nbsp;&amp; Gallagher LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">787 Seventh Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, NY
10019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Attn: Rachel C. Strickland </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Daniel Forman </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: rstrickland@willkie.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">dforman@willkie.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the
NARCO Asbestos TAC: </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">John A. Baden IV </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Motley Rice LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">28 Bridgeside
Blvd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Mt. Pleasant, South Carolina 29464 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile: (843) <FONT STYLE="white-space:nowrap">216-9290</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: jbaden@motleyrice.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Perry Weitz </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Lisa Nathanson Busch </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Weitz&nbsp;&amp; Luxenberg, PC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">700 Broadway </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">New York, New York
10003 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile: (212) <FONT STYLE="white-space:nowrap">344-5461</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: pweitz@weitzlux.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: lbusch@weitzlux.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Steven Kazan </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Kazan, McClain,
Satterley&nbsp;&amp; Greenwood, A Professional Law Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Jack London Market </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">55 Harrison Street, Suite 400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Oakland, California 94607 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile: (510) <FONT STYLE="white-space:nowrap">835-4913</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: skazan@lcazanlaw.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Steven T. Baron </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Baron&nbsp;&amp;
Budd, P.C. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">3102 Oak Lawn, Suite 1100 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Dallas, Texas 75219 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile:
(214) <FONT STYLE="white-space:nowrap">824-8100</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: sbaron@baronbudd.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Bruce Mattock </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Goldberg,
Persky&nbsp;&amp; White, P.C. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">11 Stanwix Street, Suite 1800 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Pittsburgh, Pennsylvania 15222 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile: (412) <FONT STYLE="white-space:nowrap">471-8308</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: bmattock@gpwlaw.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">John
D. Cooney </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Cooney&nbsp;&amp; Conway, LLP </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">120 N. Lasalle Street, Suite 3000 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Chicago, Illinois 60602 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email:
jcooney@cooneyconway.com </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Ann C. McMillan </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">James P. Wehner
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Caplin&nbsp;&amp; Drysdale, Chartered </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">One Thomas Circle, N.W. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Washington, DC 20005 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile:
(202) <FONT STYLE="white-space:nowrap">429-3301</FONT> </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: amcmillan@capdale.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: jwehner@capdale.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To the FCR: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Lawrence Fitzpatrick </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">200
American Metro Blvd. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Suite 129 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Hamilton, New Jersey 08619 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile: (609) <FONT STYLE="white-space:nowrap">620-1466</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: Larry.Fitzpatrick@pace-claims.com </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">with a copy (which will not constitute notice) to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">James L. Patton, Jr. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Edwin J.
Harron </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Sharon M. Zieg </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Young
Conaway Stargatt&nbsp;&amp; Taylor, LLP </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Rodney Square </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">1000 North King Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Wilmington, Delaware 19801 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Facsimile: (302) <FONT STYLE="white-space:nowrap">571-1253</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: jpatton@ycst.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email:
eharron@ycst.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Email: Szieg@ycst.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[</B><I>Signature Pages Follow</I><B>]</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Agreement to be duly executed as of the
date first written above. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">HONEYWELL INTERNATIONAL INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Lynn A. Dummett</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Lynn A. Dummett</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Vice President and General Counsel, Litigation</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">NORTH AMERICAN REFRACTORIES COMPANY ASBESTOS PERSONAL INJURY SETTLEMENT TRUST</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Richard Schiro</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Richard Schiro</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ken Kawaichi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Ken Kawaichi</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Mark Gleason</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Mark Gleason</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Trustee</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">NARCO TRUST ADVISORY COMMITTEE:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[___________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[___________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[___________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[___________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">[___________]</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FUTURE CLAIMANTS REPRESENTATIVE:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lawrence Fitzpatrick</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hon-20221118.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 11/19/2022 3:16:24 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:hon="http://honeywell.com/20221118"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://honeywell.com/20221118"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hon-20221118_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hon-20221118_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hon-20221118_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="hon_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="hon_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="hon_EuroNotes130Due2023Member" name="EuroNotes130Due2023Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="hon_M0.000SeniorNotesDue2024Member" name="M0.000SeniorNotesDue2024Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="hon_EuroNotes225Due2028Member" name="EuroNotes225Due2028Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="hon_M0.750SeniorNotesDue2032Member" name="M0.750SeniorNotesDue2032Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>hon-20221118_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 11/19/2022 3:16:26 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hon-20221118.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="hon-20221118.xsd#hon_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="hon_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="hon-20221118.xsd#hon_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="hon_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="hon-20221118.xsd#hon_EuroNotes130Due2023Member" xlink:type="locator" xlink:label="hon_EuroNotes130Due2023Member" />
    <link:loc xlink:href="hon-20221118.xsd#hon_M0.000SeniorNotesDue2024Member" xlink:type="locator" xlink:label="hon_M0.000SeniorNotesDue2024Member" />
    <link:loc xlink:href="hon-20221118.xsd#hon_EuroNotes225Due2028Member" xlink:type="locator" xlink:label="hon_EuroNotes225Due2028Member" />
    <link:loc xlink:href="hon-20221118.xsd#hon_M0.750SeniorNotesDue2032Member" xlink:type="locator" xlink:label="hon_M0.750SeniorNotesDue2032Member" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:type="locator" xlink:label="dei_AmendmentDescription" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="hon_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="hon_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hon_EuroNotes130Due2023Member" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hon_M0.000SeniorNotesDue2024Member" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hon_EuroNotes225Due2028Member" order="27" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hon_M0.750SeniorNotesDue2032Member" order="28" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="30.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="31.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="32.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="52.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="53.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="54.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentDescription" order="55.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>hon-20221118_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 11/19/2022 3:16:24 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:type="locator" xlink:label="dei_AmendmentDescription" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Description</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentDescription_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Description</link:label>
    <link:loc xlink:href="hon-20221118.xsd#hon_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="hon_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hon_DocumentAndEntityInformationTable" xlink:to="hon_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="hon_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="hon_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="hon-20221118.xsd#hon_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="hon_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="hon_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="hon_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="hon_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="hon-20221118.xsd#hon_EuroNotes130Due2023Member" xlink:type="locator" xlink:label="hon_EuroNotes130Due2023Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hon_EuroNotes130Due2023Member" xlink:to="hon_EuroNotes130Due2023Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="hon_EuroNotes130Due2023Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Euro Notes 130 Due 2023 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="hon_EuroNotes130Due2023Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Euro Notes 130 Due 2023 [Member]</link:label>
    <link:loc xlink:href="hon-20221118.xsd#hon_M0.000SeniorNotesDue2024Member" xlink:type="locator" xlink:label="hon_M0.000SeniorNotesDue2024Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hon_M0.000SeniorNotesDue2024Member" xlink:to="hon_M0.000SeniorNotesDue2024Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="hon_M0.000SeniorNotesDue2024Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">M 0.000 Senior Notes Due 2024 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="hon_M0.000SeniorNotesDue2024Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">M 0.000 Senior Notes Due 2024 [Member]</link:label>
    <link:loc xlink:href="hon-20221118.xsd#hon_EuroNotes225Due2028Member" xlink:type="locator" xlink:label="hon_EuroNotes225Due2028Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hon_EuroNotes225Due2028Member" xlink:to="hon_EuroNotes225Due2028Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="hon_EuroNotes225Due2028Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Euro Notes 225 Due 2028 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="hon_EuroNotes225Due2028Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Euro Notes 225 Due 2028 [Member]</link:label>
    <link:loc xlink:href="hon-20221118.xsd#hon_M0.750SeniorNotesDue2032Member" xlink:type="locator" xlink:label="hon_M0.750SeniorNotesDue2032Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="hon_M0.750SeniorNotesDue2032Member" xlink:to="hon_M0.750SeniorNotesDue2032Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="hon_M0.750SeniorNotesDue2032Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">M 0.750 Senior Notes Due 2032 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="hon_M0.750SeniorNotesDue2032Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">M 0.750 Senior Notes Due 2032 [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>hon-20221118_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 11/19/2022 3:16:24 AM Eastern Time -->
<!-- Copyright (c) 2022 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="hon-20221118.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="hon-20221118.xsd#hon_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="hon_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="hon_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="hon-20221118.xsd#hon_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="hon_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationTable" xlink:to="hon_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="hon-20221118.xsd#hon_EuroNotes130Due2023Member" xlink:type="locator" xlink:label="hon_EuroNotes130Due2023Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hon_EuroNotes130Due2023Member" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="hon-20221118.xsd#hon_M0.000SeniorNotesDue2024Member" xlink:type="locator" xlink:label="hon_M0.000SeniorNotesDue2024Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hon_M0.000SeniorNotesDue2024Member" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="hon-20221118.xsd#hon_EuroNotes225Due2028Member" xlink:type="locator" xlink:label="hon_EuroNotes225Due2028Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hon_EuroNotes225Due2028Member" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="hon-20221118.xsd#hon_M0.750SeniorNotesDue2032Member" xlink:type="locator" xlink:label="hon_M0.750SeniorNotesDue2032Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="hon_M0.750SeniorNotesDue2032Member" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="53.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="54.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:type="locator" xlink:label="dei_AmendmentDescription" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="hon_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentDescription" order="55.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140403682616288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 18, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hon_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HONEYWELL INTERNATIONAL INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000773840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 18,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-8974<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-2640650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">855 South Mint Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Charlotte<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">28202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">627-6200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">On November&#160;18, 2022, Honeywell International Inc. (&#8220;Honeywell&#8221;) filed a Current Report on Form 8-K (the &#8220;Original Form 8-K&#8221;) with the Securities and Exchange Commission disclosing, among other things, that Honeywell had entered into a definitive agreement (the &#8220;Buyout Agreement&#8221;) with the North American Refractories Asbestos Personal Injury Settlement Trust (the &#8220;Trust&#8221;), providing for the elimination of Honeywell&#8217;s funding obligations to the Trust. In the Original Form 8-K, Honeywell stated that it intended to file a copy of the Buyout Agreement as an exhibit to an amendment to the Original Form 8-K. Honeywell is now filing this Amendment No.&#160;1 to the Original Form 8-K (&#8220;Amendment No.&#160;1&#8221;) solely to file the Buyout Agreement as an exhibit. This Amendment No.&#160;1 does not change any previously reported information or any disclosure contained in the Original Form 8-K. <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hon_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $1 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HON<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hon_EuroNotes130Due2023Member', window );">Euro Notes 130 Due 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hon_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.300% Senior Notes due 2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HON 23A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hon_M0.000SeniorNotesDue2024Member', window );">M 0.000 Senior Notes Due 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hon_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">0.000% Senior Notes due 2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HON 24A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hon_EuroNotes225Due2028Member', window );">Euro Notes 225 Due 2028 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hon_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">2.250% Senior Notes due 2028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HON 28A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hon_M0.750SeniorNotesDue2032Member', window );">M 0.750 Senior Notes Due 2032 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hon_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">0.750% Senior Notes due 2032<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HON 32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hon_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hon_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hon_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hon_EuroNotes130Due2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hon_EuroNotes130Due2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hon_M0.000SeniorNotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hon_M0.000SeniorNotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hon_EuroNotes225Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hon_EuroNotes225Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hon_M0.750SeniorNotesDue2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hon_M0.750SeniorNotesDue2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d393319d8ka_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:hon="http://honeywell.com/20221118"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hon-20221118.xsd" xlink:type="simple"/>
    <context id="duration_2022-11-18_to_2022-11-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000773840</identifier>
        </entity>
        <period>
            <startDate>2022-11-18</startDate>
            <endDate>2022-11-18</endDate>
        </period>
    </context>
    <context id="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000773840</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-18</startDate>
            <endDate>2022-11-18</endDate>
        </period>
    </context>
    <context id="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes130Due2023Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000773840</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hon:EuroNotes130Due2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-18</startDate>
            <endDate>2022-11-18</endDate>
        </period>
    </context>
    <context id="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.000SeniorNotesDue2024Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000773840</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hon:M0.000SeniorNotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-18</startDate>
            <endDate>2022-11-18</endDate>
        </period>
    </context>
    <context id="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes225Due2028Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000773840</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hon:EuroNotes225Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-18</startDate>
            <endDate>2022-11-18</endDate>
        </period>
    </context>
    <context id="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.750SeniorNotesDue2032Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000773840</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hon:M0.750SeniorNotesDue2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-18</startDate>
            <endDate>2022-11-18</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2022-11-18_to_2022-11-18"
      id="Hidden_dei_EntityRegistrantName">HONEYWELL INTERNATIONAL INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2022-11-18_to_2022-11-18">true</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2022-11-18_to_2022-11-18"
      id="Hidden_dei_EntityCentralIndexKey">0000773840</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2022-11-18_to_2022-11-18">8-K/A</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2022-11-18_to_2022-11-18">2022-11-18</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2022-11-18_to_2022-11-18">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2022-11-18_to_2022-11-18">1-8974</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2022-11-18_to_2022-11-18">22-2640650</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2022-11-18_to_2022-11-18">855 South Mint Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2022-11-18_to_2022-11-18">Charlotte</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2022-11-18_to_2022-11-18">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2022-11-18_to_2022-11-18">28202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2022-11-18_to_2022-11-18">(704)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2022-11-18_to_2022-11-18">627-6200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2022-11-18_to_2022-11-18">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2022-11-18_to_2022-11-18">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2022-11-18_to_2022-11-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2022-11-18_to_2022-11-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, par value $1 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">HON</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes130Due2023Member">1.300% Senior Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes130Due2023Member">HON 23A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes130Due2023Member">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.000SeniorNotesDue2024Member">0.000% Senior Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.000SeniorNotesDue2024Member">HON 24A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.000SeniorNotesDue2024Member">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes225Due2028Member">2.250% Senior Notes due 2028</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes225Due2028Member">HON 28A</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-EuroNotes225Due2028Member">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.750SeniorNotesDue2032Member">0.750% Senior Notes due 2032</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.750SeniorNotesDue2032Member">HON 32</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2022-11-18_to_2022-11-18_us-gaap-StatementClassOfStockAxis_hon-M0.750SeniorNotesDue2032Member">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2022-11-18_to_2022-11-18">false</dei:EntityEmergingGrowthCompany>
    <dei:AmendmentDescription contextRef="duration_2022-11-18_to_2022-11-18">On November&#160;18, 2022, Honeywell International Inc. (&#x201c;Honeywell&#x201d;) filed a Current Report on Form 8-K (the &#x201c;Original Form 8-K&#x201d;) with the Securities and Exchange Commission disclosing, among other things, that Honeywell had entered into a definitive agreement (the &#x201c;Buyout Agreement&#x201d;) with the North American Refractories Asbestos Personal Injury Settlement Trust (the &#x201c;Trust&#x201d;), providing for the elimination of Honeywell&#x2019;s funding obligations to the Trust. In the Original Form 8-K, Honeywell stated that it intended to file a copy of the Buyout Agreement as an exhibit to an amendment to the Original Form 8-K. Honeywell is now filing this Amendment No.&#160;1 to the Original Form 8-K (&#x201c;Amendment No.&#160;1&#x201d;) solely to file the Buyout Agreement as an exhibit. This Amendment No.&#160;1 does not change any previously reported information or any disclosure contained in the Original Form 8-K. </dei:AmendmentDescription>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " !QBW)5EXJ[',
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M<E4<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y
M$U"+5$2XE#Z0JA:5BON2=8C%/B*O RU?7R=15*1>>O)Z;(UG9A?G2,=]C$?U
MY5U(A:Z9FWF6I;(&;])-;"#(I(KD#4M+ARPU!,:F&H"]RZ9Y/LN\P:"7BY%K
M0]EU$QE*QA@$[( =PCG]SKM6G3#A'AWR=Z'[MP.M/ ;T> %;Z%RK5,?S2R2\
MQ,#&;4N*SA5Z,@QV0(SE'WC;B?PT^]0C;/8?1H04>I8+8864N-_H^8UH/($L
M#UW+\0D= ZT,PS/%ML%PZ&C$179EH\]AK$.(<_I/C+&JL(15+%L/@8<<"5PG
M,*0:FZ15,!X*/:XH$ZQZ#"PAJ748J&2W<RJGUW9PS2+W*D.:HPQH;0?AHUH+
M%0:P;W(@"2[)E1M27>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    " !QBW)5!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( '&+<E54
M]G>8[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( '&+<E697)PC$ 8  )PG   3              "  <L!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ <8MR54!QF,]P!P
M:B,  !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( '&+<E6?H!OPL0(  .(,   -              "  ;(/
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ <8MR59>*NQS     $P(   L
M             ( !CA(  %]R96QS+RYR96QS4$L! A0#%     @ <8MR51PX
M9>H_ 0  / (   \              ( !=Q,  'AL+W=O<FMB;V]K+GAM;%!+
M 0(4 Q0    ( '&+<E4D'INBK0   /@!   :              "  >,4  !X
M;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( '&+<E5ED'F2
M&0$  ,\#   3              "  <@5  !;0V]N=&5N=%]4>7!E<UTN>&UL
64$L%!@     )  D /@(  !(7      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>6</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>5</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d393319d8ka.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d393319d8ka.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K/A" original="d393319d8ka.htm">d393319d8ka.htm</File>
    <File>d393319dex101.htm</File>
    <File>hon-20221118.xsd</File>
    <File>hon-20221118_def.xml</File>
    <File>hon-20221118_lab.xml</File>
    <File>hon-20221118_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="35">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d393319d8ka.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 6,
   "dts": {
    "definitionLink": {
     "local": [
      "hon-20221118_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d393319d8ka.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hon-20221118_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hon-20221118_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hon-20221118.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 33,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 4,
   "memberStandard": 1,
   "nsprefix": "hon",
   "nsuri": "http://honeywell.com/20221118",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d393319d8ka.htm",
      "contextRef": "duration_2022-11-18_to_2022-11-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d393319d8ka.htm",
      "contextRef": "duration_2022-11-18_to_2022-11-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 5,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description",
        "terseLabel": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "hon_DocumentAndEntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationLineItems",
     "nsuri": "http://honeywell.com/20221118",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "hon_DocumentAndEntityInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationTable",
     "nsuri": "http://honeywell.com/20221118",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "hon_EuroNotes130Due2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Notes 130 Due 2023 [Member]",
        "terseLabel": "Euro Notes 130 Due 2023 [Member]"
       }
      }
     },
     "localname": "EuroNotes130Due2023Member",
     "nsuri": "http://honeywell.com/20221118",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "hon_EuroNotes225Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Notes 225 Due 2028 [Member]",
        "terseLabel": "Euro Notes 225 Due 2028 [Member]"
       }
      }
     },
     "localname": "EuroNotes225Due2028Member",
     "nsuri": "http://honeywell.com/20221118",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "hon_M0.000SeniorNotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "M 0.000 Senior Notes Due 2024 [Member]",
        "terseLabel": "M 0.000 Senior Notes Due 2024 [Member]"
       }
      }
     },
     "localname": "M0.000SeniorNotesDue2024Member",
     "nsuri": "http://honeywell.com/20221118",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "hon_M0.750SeniorNotesDue2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "M 0.750 Senior Notes Due 2032 [Member]",
        "terseLabel": "M 0.750 Senior Notes Due 2032 [Member]"
       }
      }
     },
     "localname": "M0.750SeniorNotesDue2032Member",
     "nsuri": "http://honeywell.com/20221118",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://honeywell.com//20221118/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-22-289156-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-22-289156-xbrl.zip
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MXV6;X"<B%+-7'>!>I5O"&L"3CM>U;_X'4$L#!!0    ( '&+<E7> @5'&'0
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MN.41''@P'D=Q!%=^Y(W" 7P_]U8ZCF*/G[%'RL(T.PL26,?(*V%U&7UCFJ5
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MO#8@:"O7 /?,UA^ZP-%9>6!Y65\?ZIGS%ZAWSLI@(8K."Z5RLJ65I-X$7;C
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MILKS5L"PI$E0+%$PAZY@1N?0$W5PO7EV<-V1$/RT\WES8]VS%%8#+?.P2EN
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MR#0)K94#\IZT83"EYM[<J:ON)'7&8S?5I;(3?I$12?R]J3!@+FY*VH013R<
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M A9YP'5M^^OA9_#G"KT-GA!!4" 002$1![_%F(3M1KW1\/WZ1>U\W8PCJ/%
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M952*GVX6P132"2IR,DFW+6'7N(D0GR@/_,[97$[5-)I!6O XL >BG&-4#XF
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M#O4]F +G$-RF3;,OZB1D-:0*2$I^=WBJ4\!00B2^!\ M9V\&L5ZV5@"[)<K
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MW-'_]".]ZLH_4$L! A0#%     @ <8MR5237P<O+$   F84   \
M     ( !     &0S.3,S,3ED.&MA+FAT;5!+ 0(4 Q0    ( '&+<E7> @5'
M&'0  /:F @ 1              "  ?@0  !D,SDS,S$Y9&5X,3 Q+FAT;5!+
M 0(4 Q0    ( '&+<E5*SH_7-P0  )<2   0              "  3^%  !H
M;VXM,C R,C$Q,3@N>'-D4$L! A0#%     @ <8MR5:>>I,8B!@  P#D  !0
M             ( !I(D  &AO;BTR,#(R,3$Q.%]D968N>&UL4$L! A0#%
M  @ <8MR52U:=7>%"   B6$  !0              ( !^(\  &AO;BTR,#(R
M,3$Q.%]L86(N>&UL4$L! A0#%     @ <8MR58EEMK'C!0  3#X  !0
M         ( !KY@  &AO;BTR,#(R,3$Q.%]P<F4N>&UL4$L%!@     &  8
*@ $  ,2>      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
